<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Metformin,Oral hypoglycemics and insulin analogs,1995,2007,AICA ribonucleotide,AMP-activated protein kinase,ATC code A10,ATP-sensitive potassium channel,Acarbose,Adenosine monophosphate,Adenosine triphosphate" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Metformin&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Metformin&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Metformin - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Metformin";
		var wgTitle = "Metformin";
		var wgAction = "view";
		var wgArticleId = "253720";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 276830151;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Metformin skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Metformin</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<table id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" class="toccolours" border="0" cellpadding="1" align="right" width="280">
<tr>
<td align="center" colspan="2"><a href="/wiki/File:Metformin.svg" class="image" title="Metformin.svg"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/4/46/Metformin.svg/220px-Metformin.svg.png" width="220" height="125" border="0" /></a></td>
</tr>
<tr>
<td align="center" colspan="2"><a href="/wiki/File:Metformin-from-xtal-3D-balls.png" class="image" title="Metformin-from-xtal-3D-balls.png"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/3/34/Metformin-from-xtal-3D-balls.png/200px-Metformin-from-xtal-3D-balls.png" width="200" height="190" border="0" /></a></td>
</tr>
<tr>
<td align="center" colspan="2">
<div style="font-size:medium; line-height:167%;">Metformin</div>
</td>
</tr>
<tr>
<td align="center" colspan="2" bgcolor="#DDDDDD"><b>Systematic (<a href="/wiki/International_Union_of_Pure_and_Applied_Chemistry_nomenclature" title="International Union of Pure and Applied Chemistry nomenclature" class="mw-redirect">IUPAC</a>) name</b></td>
</tr>
<tr>
<td bgcolor="#EEEEEE" style="text-align: center; vertical-align: top;" colspan="2"><span style="font-size:11px"><i>N</i>,<i>N</i>-dimethylimidodicarbonimidic diamide</span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Identifiers</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" width="90"><a href="/wiki/CAS_registry_number" title="CAS registry number">CAS number</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=657-24-9&amp;rn=1" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=657-24-9&amp;rn=1" rel="nofollow">657-24-9</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></td>
<td bgcolor="#EEEEEE"><a href="/wiki/ATC_code_A10" title="ATC code A10">A10</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=A10BA02" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=A10BA02" rel="nofollow">BA02</a></span><br />
<a href="/wiki/ATC_code_A10" title="ATC code A10">A10</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=A10BD02" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=A10BD02" rel="nofollow">BD02</a></span> (with <a href="/wiki/Sulfonylurea" title="Sulfonylurea">sulfonylureas</a>)<br />
<a href="/wiki/ATC_code_A10" title="ATC code A10">A10</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=A10BD03" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=A10BD03" rel="nofollow">BD03</a></span> (with <a href="/wiki/Rosiglitazone" title="Rosiglitazone">rosiglitazone</a>)<br />
<a href="/wiki/ATC_code_A10" title="ATC code A10">A10</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=A10BD05" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=A10BD05" rel="nofollow">BD05</a></span> (with <a href="/wiki/Pioglitazone" title="Pioglitazone">pioglitazone</a>)<br />
<a href="/wiki/ATC_code_A10" title="ATC code A10">A10</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=A10BD07" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=A10BD07" rel="nofollow">BD07</a></span> (with <a href="/wiki/Sitagliptin" title="Sitagliptin">sitagliptin</a>)<br />
<a href="/wiki/ATC_code_A10" title="ATC code A10">A10</a><span class="reflink plainlinksneverexpand"><a href="http://www.whocc.no/atcddd/indexdatabase/index.php?query=A10BD08" class="external text" title="http://www.whocc.no/atcddd/indexdatabase/index.php?query=A10BD08" rel="nofollow">BD08</a></span> (with <a href="/wiki/Vildagliptin" title="Vildagliptin">vildagliptin</a>)</td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/PubChem" title="PubChem">PubChem</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=4091" class="external text" title="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=4091" rel="nofollow">4091</a></span></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/DrugBank" title="DrugBank">DrugBank</a></td>
<td bgcolor="#EEEEEE"><span class="reflink plainlinksneverexpand"><a href="http://www.drugbank.ca/cgi-bin/show_drug.cgi?CARD=APRD01099" class="external text" title="http://www.drugbank.ca/cgi-bin/show_drug.cgi?CARD=APRD01099" rel="nofollow">APRD01099</a></span></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Chemical data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Chemical_formula" title="Chemical formula">Formula</a></td>
<td bgcolor="#EEEEEE"><a href="/wiki/Carbon" title="Carbon"><span style="color: rgb(000,000,000); font-weight: bold;">C</span></a><sub>4</sub><a href="/wiki/Hydrogen" title="Hydrogen"><span style="color: rgb(77,77,77); font-weight: bold;">H</span></a><sub>11</sub><a href="/wiki/Nitrogen" title="Nitrogen"><span style="color: rgb(0,0,128); font-weight: bold;">N</span></a><sub>5</sub><sup>&#160;</sup></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Molecular_mass" title="Molecular mass">Mol. mass</a></td>
<td bgcolor="#EEEEEE">129.164 g/mol<br />
165.63 g/mol (<a href="/wiki/Hydrochloride" title="Hydrochloride">hydrochloride</a>)</td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Synonym" title="Synonym">Synonyms</a></td>
<td bgcolor="#EEEEEE">1,1-dimethylbiguanide</td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Pharmacokinetic data</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Bioavailability" title="Bioavailability">Bioavailability</a></td>
<td bgcolor="#EEEEEE">50 to 60% under fasting conditions</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Drug_metabolism" title="Drug metabolism">Metabolism</a></td>
<td bgcolor="#EEEEEE">None</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Biological_half-life" title="Biological half-life">Half life</a></td>
<td bgcolor="#EEEEEE">6.2 hours</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Excretion" title="Excretion">Excretion</a></td>
<td bgcolor="#EEEEEE">Active <a href="/wiki/Kidney" title="Kidney">renal</a> tubular excretion by <a href="/wiki/SLC22A2" title="SLC22A2">OCT2</a></td>
</tr>
<tr>
<td colspan="2" bgcolor="#DDDDDD"><b>Therapeutic considerations</b></td>
</tr>
<tr>
<td bgcolor="#DDEEFF"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Licence data</a></td>
<td bgcolor="#EEEEEE">
<p><a href="/wiki/U.S._Food_and_Drug_Administration" title="U.S. Food and Drug Administration">US FDA</a>:<span class="reflink plainlinksneverexpand"><a href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;SearchTerm=Metformin&amp;SearchType=BasicSearch" class="external text" title="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;SearchTerm=Metformin&amp;SearchType=BasicSearch" rel="nofollow">link</a></span></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Pregnancy_category" title="Pregnancy category">Pregnancy cat.</a></td>
<td bgcolor="#EEEEEE">
<p>C<small>(<a href="/wiki/Australia" title="Australia">AU</a>)</small> B<small>(<a href="/wiki/United_States" title="United States">US</a>)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Legal status</a></td>
<td bgcolor="#EEEEEE">
<p><a href="/wiki/Prescription_drug" title="Prescription drug">POM</a><small>(<a href="/wiki/United_Kingdom" title="United Kingdom">UK</a>)</small> <a href="/wiki/Prescription_drug" title="Prescription drug"><span class="Unicode">℞</span><small>-only</small></a><small>(<a href="/wiki/United_States" title="United States">US</a>)</small></p>
</td>
</tr>
<tr>
<td bgcolor="#DDEEFF" style="vertical-align: top;"><a href="/wiki/Route_of_administration" title="Route of administration">Routes</a></td>
<td bgcolor="#EEEEEE">Oral</td>
</tr>
</table>
<p><b>Metformin</b> (<a href="/wiki/International_Nonproprietary_Name" title="International Nonproprietary Name">INN</a>; trade names <b>Glucophage</b>, <b>Riomet</b>, <b>Fortamet</b>, <b>Glumetza</b>, <b>Obimet</b>, <b>Dianben</b>, <b>Diabex</b>, <b>Diaformin</b>, and others) (<small>IPA</small>: <span title="Pronunciation in IPA" class="IPA"><a href="/wiki/Wikipedia:IPA_for_English" title="Wikipedia:IPA for English">/mɛtˈfɔrmɪn/</a></span>) is an oral <a href="/wiki/Anti-diabetic_drug" title="Anti-diabetic drug">anti-diabetic drug</a> from the <a href="/wiki/Biguanide" title="Biguanide">biguanide</a> class. It is the <a href="/wiki/First-line_treatment" title="First-line treatment">first-line</a> drug for the treatment of <a href="/wiki/Diabetes_mellitus_type_2" title="Diabetes mellitus type 2">type 2 diabetes</a>, particularly in <a href="/wiki/Overweight" title="Overweight">overweight</a> and <a href="/wiki/Obesity" title="Obesity">obese</a> people and those with normal kidney function,<sup id="cite_ref-0" class="reference"><a href="#cite_note-0" title=""><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-1" class="reference"><a href="#cite_note-1" title=""><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-2" class="reference"><a href="#cite_note-2" title=""><span>[</span>3<span>]</span></a></sup> and evidence suggests it may be the best choice for people with <a href="/wiki/Heart_failure" title="Heart failure">heart failure</a>.<sup id="cite_ref-Eurich_3-0" class="reference"><a href="#cite_note-Eurich-3" title=""><span>[</span>4<span>]</span></a></sup> It is also used in the treatment of <a href="/wiki/Polycystic_ovary_syndrome" title="Polycystic ovary syndrome">polycystic ovary syndrome</a>.</p>
<p>Metformin is the most popular anti-diabetic drug in the United States and one of the most prescribed drugs in the country overall, with nearly 35 million prescriptions filled in 2006 for generic metformin alone.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4" title=""><span>[</span>5<span>]</span></a></sup> When prescribed appropriately, metformin causes few <a href="/wiki/Adverse_drug_reaction" title="Adverse drug reaction">adverse effects</a>—the most common is gastrointestinal upset—and, unlike many other anti-diabetic drugs, does not cause <a href="/wiki/Hypoglycemia" title="Hypoglycemia">hypoglycemia</a> if used alone. It also helps reduce <a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">LDL cholesterol</a> and <a href="/wiki/Triglyceride" title="Triglyceride">triglyceride</a> levels, and may aid weight loss. As of 2008<sup class="plainlinks noprint asof-tag update" style="display:none;"><a href="http://en.wikipedia.org/w/index.php?title=Metformin&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Metformin&amp;action=edit" rel="nofollow">[update]</a></sup>, metformin is one of only two oral anti-diabetics in the <a href="/wiki/World_Health_Organization_Model_List_of_Essential_Medicines" title="World Health Organization Model List of Essential Medicines" class="mw-redirect">World Health Organization Model List of Essential Medicines</a> (the other being <a href="/wiki/Glibenclamide" title="Glibenclamide">glibenclamide</a>).<sup id="cite_ref-5" class="reference"><a href="#cite_note-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">1</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1"><a href="#Indications"><span class="tocnumber">2</span> <span class="toctext">Indications</span></a></li>
<li class="toclevel-1"><a href="#Contraindications"><span class="tocnumber">3</span> <span class="toctext">Contraindications</span></a></li>
<li class="toclevel-1"><a href="#Adverse_effects"><span class="tocnumber">4</span> <span class="toctext">Adverse effects</span></a>
<ul>
<li class="toclevel-2"><a href="#Lactic_acidosis"><span class="tocnumber">4.1</span> <span class="toctext">Lactic acidosis</span></a></li>
<li class="toclevel-2"><a href="#Gastrointestinal"><span class="tocnumber">4.2</span> <span class="toctext">Gastrointestinal</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Overdosage"><span class="tocnumber">5</span> <span class="toctext">Overdosage</span></a></li>
<li class="toclevel-1"><a href="#Mechanism_of_action"><span class="tocnumber">6</span> <span class="toctext">Mechanism of action</span></a></li>
<li class="toclevel-1"><a href="#Interactions"><span class="tocnumber">7</span> <span class="toctext">Interactions</span></a></li>
<li class="toclevel-1"><a href="#Formulations"><span class="tocnumber">8</span> <span class="toctext">Formulations</span></a>
<ul>
<li class="toclevel-2"><a href="#Combinations_with_other_drugs"><span class="tocnumber">8.1</span> <span class="toctext">Combinations with other drugs</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">9</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">10</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=1" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<p>The <a href="/wiki/Biguanide" title="Biguanide">biguanide</a> class of anti-diabetic drugs, which also includes the withdrawn agents <a href="/wiki/Phenformin" title="Phenformin">phenformin</a> and <a href="/wiki/Buformin" title="Buformin">buformin</a>, originates from the <a href="/wiki/Galega_officinalis" title="Galega officinalis">French lilac</a> (<i>Galega officinalis</i>), a plant known for several centuries to reduce the symptoms of <a href="/wiki/Diabetes_mellitus" title="Diabetes mellitus">diabetes mellitus</a>.<sup id="cite_ref-Witters_6-0" class="reference"><a href="#cite_note-Witters-6" title=""><span>[</span>7<span>]</span></a></sup></p>
<p>Metformin was first described in the scientific literature in 1957.<sup id="cite_ref-Ungar_7-0" class="reference"><a href="#cite_note-Ungar-7" title=""><span>[</span>8<span>]</span></a></sup> It was first marketed in France in 1979, but did not receive approval by the U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration" class="mw-redirect">Food and Drug Administration</a> (FDA) for Type 2 diabetes until 1994.<sup id="cite_ref-FDAapproval_8-0" class="reference"><a href="#cite_note-FDAapproval-8" title=""><span>[</span>9<span>]</span></a></sup> <a href="/wiki/Bristol-Myers_Squibb" title="Bristol-Myers Squibb">Bristol-Myers Squibb</a>'s Glucophage was the first branded formulation of metformin to be marketed in the United States, beginning on <span class="mw-formatted-date" title="1995-03-03"><span class="mw-formatted-date" title="03-03"><a href="/wiki/March_3" title="March 3">March 3</a></span>, <a href="/wiki/1995" title="1995">1995</a></span>.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9" title=""><span>[</span>10<span>]</span></a></sup> <a href="/wiki/Generic_drug" title="Generic drug">Generic</a> formulations are now available.</p>
<p><a name="Indications" id="Indications"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=2" title="Edit section: Indications">edit</a>]</span> <span class="mw-headline">Indications</span></h2>
<p>The main use for metformin is in the treatment of <a href="/wiki/Diabetes_mellitus_type_2" title="Diabetes mellitus type 2">diabetes mellitus type 2</a>, especially when this accompanies <a href="/wiki/Obesity" title="Obesity">obesity</a> and <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin resistance</a>. Metformin is the only anti-diabetic drug that has been proven to protect against the cardiovascular complications of diabetes.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10" title=""><span>[</span>11<span>]</span></a></sup> This was first shown in the <a href="/wiki/United_Kingdom_Prospective_Diabetes_Study" title="United Kingdom Prospective Diabetes Study">United Kingdom Prospective Diabetes Study</a>, a large study of overweight patients with diabetes.<sup id="cite_ref-UKPDS_11-0" class="reference"><a href="#cite_note-UKPDS-11" title=""><span>[</span>12<span>]</span></a></sup> Unlike the other most-commonly prescribed class of oral diabetes drugs, the <a href="/wiki/Sulfonylurea" title="Sulfonylurea">sulfonylureas</a>, metformin (taken alone) does not induce <a href="/wiki/Hypoglycemia" title="Hypoglycemia">hypoglycemia</a>.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12" title=""><span>[</span>13<span>]</span></a></sup> Hypoglycemia during intense exercise has been documented, but is extremely rare.<sup id="cite_ref-isbn0071416137_13-0" class="reference"><a href="#cite_note-isbn0071416137-13" title=""><span>[</span>14<span>]</span></a></sup> It also does not cause weight gain, and may indeed produce minor weight loss.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14" title=""><span>[</span>15<span>]</span></a></sup> Metformin also modestly reduces <a href="/wiki/Low_density_lipoprotein" title="Low density lipoprotein" class="mw-redirect">LDL</a> and <a href="/wiki/Triglyceride" title="Triglyceride">triglyceride</a> levels.<sup id="cite_ref-Bolen_15-0" class="reference"><a href="#cite_note-Bolen-15" title=""><span>[</span>16<span>]</span></a></sup></p>
<p>It is also being used increasingly in <a href="/wiki/Polycystic_ovary_syndrome" title="Polycystic ovary syndrome">polycystic ovary syndrome</a> (PCOS),<sup id="cite_ref-Lord_16-0" class="reference"><a href="#cite_note-Lord-16" title=""><span>[</span>17<span>]</span></a></sup> <a href="/wiki/Non-alcoholic_fatty_liver_disease" title="Non-alcoholic fatty liver disease">non-alcoholic fatty liver disease</a> (NAFLD)<sup id="cite_ref-Marchesini_17-0" class="reference"><a href="#cite_note-Marchesini-17" title=""><span>[</span>18<span>]</span></a></sup> and premature puberty,<sup id="cite_ref-18" class="reference"><a href="#cite_note-18" title=""><span>[</span>19<span>]</span></a></sup> three other diseases that feature <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin resistance</a>; these indications are still<sup class="plainlinks noprint asof-tag update" style="display:none;"><a href="http://en.wikipedia.org/w/index.php?title=Metformin&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Metformin&amp;action=edit" rel="nofollow">[update]</a></sup> considered experimental. Although metformin is <a href="/wiki/Off-label_use" title="Off-label use">not licensed</a> for use in PCOS, the United Kingdom's <a href="/wiki/National_Institute_for_Health_and_Clinical_Excellence" title="National Institute for Health and Clinical Excellence">National Institute for Health and Clinical Excellence</a> recommends that women with PCOS and a <a href="/wiki/Body_mass_index" title="Body mass index">body mass index</a> above 25 be given metformin when other therapy has failed to produce results.<sup id="cite_ref-NICE2004_19-0" class="reference"><a href="#cite_note-NICE2004-19" title=""><span>[</span>20<span>]</span></a></sup> The benefit of metformin in NAFLD has not been extensively studied and may be only temporary.<sup id="cite_ref-Nair_20-0" class="reference"><a href="#cite_note-Nair-20" title=""><span>[</span>21<span>]</span></a></sup></p>
<p>It may reduce weight gain in patients taking <a href="/wiki/Atypical_antipsychotic" title="Atypical antipsychotic">atypical antipsychotics</a>.<sup id="cite_ref-pmid18182600_21-0" class="reference"><a href="#cite_note-pmid18182600-21" title=""><span>[</span>22<span>]</span></a></sup></p>
<p><a name="Contraindications" id="Contraindications"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=3" title="Edit section: Contraindications">edit</a>]</span> <span class="mw-headline">Contraindications</span></h2>
<p>Metformin is <a href="/wiki/Contraindication" title="Contraindication">contraindicated</a> in people with any condition that could increase the risk of <a href="/wiki/Lactic_acidosis" title="Lactic acidosis">lactic acidosis</a>, including <a href="/wiki/Kidney" title="Kidney">kidney</a> disorders (<a href="/wiki/Creatinine" title="Creatinine">creatinine</a> levels over 150 μmol/l,<sup id="cite_ref-Jones2003_22-0" class="reference"><a href="#cite_note-Jones2003-22" title=""><span>[</span>23<span>]</span></a></sup> although this is an arbitrary limit), <a href="/wiki/Lung_disease" title="Lung disease" class="mw-redirect">lung disease</a> and <a href="/wiki/Liver_disease" title="Liver disease">liver disease</a>. <a href="/wiki/Heart_failure" title="Heart failure">Heart failure</a> has long been considered a contraindication for metformin use, although a 2007 <a href="/wiki/Systematic_review" title="Systematic review">systematic review</a> showed metformin to be the only anti-diabetic drug <i>not</i> associated with harm in people with heart failure.<sup id="cite_ref-Eurich_3-1" class="reference"><a href="#cite_note-Eurich-3" title=""><span>[</span>4<span>]</span></a></sup></p>
<p>It is recommended that metformin be temporarily discontinued before any <a href="/wiki/Medical_imaging" title="Medical imaging">radiographic study</a> involving <a href="/wiki/Iodine" title="Iodine">iodinated</a> <a href="/wiki/Radiocontrast" title="Radiocontrast">contrast</a> (such as a contrast-enhanced <a href="/wiki/Computed_tomography" title="Computed tomography">CT scan</a> or <a href="/wiki/Angiogram" title="Angiogram" class="mw-redirect">angiogram</a>), as contrast dye may temporarily impair kidney function, indirectly leading to lactic acidosis by causing retention of metformin in the body.<sup id="cite_ref-RCR_23-0" class="reference"><a href="#cite_note-RCR-23" title=""><span>[</span>24<span>]</span></a></sup><sup id="cite_ref-ESUR_24-0" class="reference"><a href="#cite_note-ESUR-24" title=""><span>[</span>25<span>]</span></a></sup> It is recommended that metformin be resumed after two days, assuming kidney function is normal.<sup id="cite_ref-RCR_23-1" class="reference"><a href="#cite_note-RCR-23" title=""><span>[</span>24<span>]</span></a></sup><sup id="cite_ref-ESUR_24-1" class="reference"><a href="#cite_note-ESUR-24" title=""><span>[</span>25<span>]</span></a></sup></p>
<p><a name="Adverse_effects" id="Adverse_effects"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=4" title="Edit section: Adverse effects">edit</a>]</span> <span class="mw-headline">Adverse effects</span></h2>
<p><a name="Lactic_acidosis" id="Lactic_acidosis"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=5" title="Edit section: Lactic acidosis">edit</a>]</span> <span class="mw-headline">Lactic acidosis</span></h3>
<p>The most serious potential <a href="/wiki/Adverse_drug_reaction" title="Adverse drug reaction">side effect</a> of metformin is <a href="/wiki/Lactic_acidosis" title="Lactic acidosis">lactic acidosis</a>; this complication is very rare, and seems limited to those with impaired liver or kidney function. <a href="/wiki/Phenformin" title="Phenformin">Phenformin</a>, another biguanide, was withdrawn because of an increased risk of lactic acidosis (up to 60 cases per <a href="/wiki/Million" title="Million">million</a> patient-years). However, metformin is safer than phenformin, and the risk of developing lactic acidosis is not increased by the medication so long as it is not prescribed to known high-risk groups.<sup id="cite_ref-Salpeter_25-0" class="reference"><a href="#cite_note-Salpeter-25" title=""><span>[</span>26<span>]</span></a></sup></p>
<p><a name="Gastrointestinal" id="Gastrointestinal"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=6" title="Edit section: Gastrointestinal">edit</a>]</span> <span class="mw-headline">Gastrointestinal</span></h3>
<p>The most common adverse effect of metformin is gastrointestinal upset, including <a href="/wiki/Diarrhea" title="Diarrhea">diarrhea</a>, cramps, nausea, vomiting and increased <a href="/wiki/Flatulence" title="Flatulence">flatulence</a>; metformin is more commonly associated with gastrointestinal side effects than most other anti-diabetic drugs.<sup id="cite_ref-Bolen_15-1" class="reference"><a href="#cite_note-Bolen-15" title=""><span>[</span>16<span>]</span></a></sup> In a clinical trial of 286 subjects, 53.2% of the 141 who were given immediate-release metformin (as opposed to <a href="/wiki/Placebo" title="Placebo">placebo</a>) reported diarrhea, versus 11.7% for placebo, and 25.5% reported nausea/vomiting, versus 8.3% for those on placebo.<sup id="cite_ref-DF.26C_26-0" class="reference"><a href="#cite_note-DF.26C-26" title=""><span>[</span>27<span>]</span></a></sup></p>
<p>Gastrointestinal upset can cause severe discomfort for patients; it is most common when metformin is first administered, or when the dose is increased. The discomfort can often be avoided by beginning at a low dose (1 to 1.7 grams per day) and increasing the dose gradually. Gastrointestinal upset after prolonged, steady use is less common.</p>
<p>Long-term use of metformin has been associated with increased <a href="/wiki/Homocysteine" title="Homocysteine">homocysteine</a> levels<sup id="cite_ref-Wulffele_27-0" class="reference"><a href="#cite_note-Wulffele-27" title=""><span>[</span>28<span>]</span></a></sup> and <a href="/wiki/Malabsorption" title="Malabsorption">malabsorption</a> of <a href="/wiki/Cyanocobalamin" title="Cyanocobalamin">vitamin B<sub>12</sub></a>.<sup id="cite_ref-Andres_28-0" class="reference"><a href="#cite_note-Andres-28" title=""><span>[</span>29<span>]</span></a></sup><sup id="cite_ref-Gilligan_29-0" class="reference"><a href="#cite_note-Gilligan-29" title=""><span>[</span>30<span>]</span></a></sup> Higher doses and prolonged use are associated with increased incidence of B<sub>12</sub> deficiency, and some researchers recommend screening or prevention strategies.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30" title=""><span>[</span>31<span>]</span></a></sup></p>
<p><a name="Overdosage" id="Overdosage"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=7" title="Edit section: Overdosage">edit</a>]</span> <span class="mw-headline">Overdosage</span></h2>
<p>A review of intentional and accidental metformin overdoses reported to <a href="/wiki/Poison_control_center" title="Poison control center">Poison control centers</a> over a 5-year period found that serious adverse events were rare, though elderly patients appeared to be at greater risk.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31" title=""><span>[</span>32<span>]</span></a></sup> Intentional overdoses with up to 63 g of metformin have been reported in the medical literature.<sup id="cite_ref-63g_32-0" class="reference"><a href="#cite_note-63g-32" title=""><span>[</span>33<span>]</span></a></sup> The major potentially life-threatening complication of metformin overdose is <a href="/wiki/Lactic_acidosis" title="Lactic acidosis">lactic acidosis</a>. Treatment of metformin overdose is generally supportive, but may include <a href="/wiki/Sodium_bicarbonate" title="Sodium bicarbonate">sodium bicarbonate</a> to address acidosis and <a href="/wiki/Hemodialysis" title="Hemodialysis">standard hemodialysis</a> or <a href="/wiki/Hemofiltration" title="Hemofiltration">continuous veno-venous hemofiltration</a> to rapidly remove metformin and correct acidosis.<sup id="cite_ref-cvvh_33-0" class="reference"><a href="#cite_note-cvvh-33" title=""><span>[</span>34<span>]</span></a></sup><sup id="cite_ref-hd_34-0" class="reference"><a href="#cite_note-hd-34" title=""><span>[</span>35<span>]</span></a></sup></p>
<p><a name="Mechanism_of_action" id="Mechanism_of_action"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=8" title="Edit section: Mechanism of action">edit</a>]</span> <span class="mw-headline">Mechanism of action</span></h2>
<p>Metformin improves hyperglycemia primarily through its suppression of hepatic glucose production (hepatic <a href="/wiki/Gluconeogenesis" title="Gluconeogenesis">gluconeogenesis</a>).<sup id="cite_ref-Kirpichnikov_35-0" class="reference"><a href="#cite_note-Kirpichnikov-35" title=""><span>[</span>36<span>]</span></a></sup> The "average" person with type 2 diabetes has three times the normal rate of gluconeogenesis; metformin treatment reduces this by over one third.<sup id="cite_ref-Hundal_36-0" class="reference"><a href="#cite_note-Hundal-36" title=""><span>[</span>37<span>]</span></a></sup> Metformin activates <a href="/wiki/AMP-activated_protein_kinase" title="AMP-activated protein kinase">AMP-activated protein kinase</a> (AMPK), a liver enzyme that plays an important role in insulin signaling, whole body energy balance, and the metabolism of glucose and <a href="/wiki/Lipid" title="Lipid">fats</a>;<sup id="cite_ref-37" class="reference"><a href="#cite_note-37" title=""><span>[</span>38<span>]</span></a></sup> activation of AMPK is required for metformin's inhibitory effect on the production of glucose by liver cells.<sup id="cite_ref-Zhou_38-0" class="reference"><a href="#cite_note-Zhou-38" title=""><span>[</span>39<span>]</span></a></sup> Research published in 2008 further elucidated metformin's mechanism of action, showing that activation of AMPK is required for an increase in the expression of <a href="/wiki/Small_heterodimer_partner" title="Small heterodimer partner">SHP</a>, which in turn inhibits the <a href="/wiki/Gene_expression" title="Gene expression">expression</a> of the hepatic gluconeogenic genes <a href="/wiki/Phosphoenolpyruvate_carboxykinase" title="Phosphoenolpyruvate carboxykinase">PEPCK</a> and <a href="/wiki/Glucose_6-phosphatase" title="Glucose 6-phosphatase">Glc-6-Pase</a>.<sup id="cite_ref-39" class="reference"><a href="#cite_note-39" title=""><span>[</span>40<span>]</span></a></sup> Metformin is frequently used in research along with <a href="/wiki/AICA_ribonucleotide" title="AICA ribonucleotide">AICAR</a> as an AMPK agonist. The mechanism by which biguanides increase the activity of AMPK remains uncertain; however, research suggests that metformin increases the amount of <a href="/wiki/Cytosol" title="Cytosol">cytosolic</a> <a href="/wiki/Adenosine_monophosphate" title="Adenosine monophosphate">AMP</a> (as opposed to a change in total AMP or total AMP/<a href="/wiki/Adenosine_triphosphate" title="Adenosine triphosphate">ATP</a>).<sup id="cite_ref-40" class="reference"><a href="#cite_note-40" title=""><span>[</span>41<span>]</span></a></sup></p>
<p>In addition to suppressing hepatic glucose production, metformin increases insulin sensitivity, enhances peripheral <a href="/wiki/Glucose_uptake" title="Glucose uptake">glucose uptake</a>, increases <a href="/wiki/Fatty_acid_metabolism" title="Fatty acid metabolism">fatty acid oxidation</a>,<sup id="cite_ref-41" class="reference"><a href="#cite_note-41" title=""><span>[</span>42<span>]</span></a></sup> and decreases absorption of glucose from the <a href="/wiki/Gastrointestinal_tract" title="Gastrointestinal tract">gastrointestinal tract</a>. Increased peripheral utilization of glucose may be due to improved insulin binding to insulin receptors.<sup id="cite_ref-42" class="reference"><a href="#cite_note-42" title=""><span>[</span>43<span>]</span></a></sup> AMPK probably also plays a role, as metformin administration increases AMPK activity in skeletal muscle.<sup id="cite_ref-43" class="reference"><a href="#cite_note-43" title=""><span>[</span>44<span>]</span></a></sup> AMPK is known to cause <a href="/wiki/GLUT4" title="GLUT4">GLUT4</a> translocation, resulting in insulin-independent glucose uptake. Some metabolic actions of metformin do appear to occur by AMPK-independent mechanisms; a recent study found that "the metabolic actions of metformin in the heart muscle can occur independent of changes in AMPK activity and may be mediated by <a href="/wiki/P38_mitogen-activated_protein_kinases" title="P38 mitogen-activated protein kinases">p38 MAPK</a>- and <a href="/wiki/Protein_kinase_C" title="Protein kinase C">PKC</a>-dependent mechanisms."<sup id="cite_ref-44" class="reference"><a href="#cite_note-44" title=""><span>[</span>45<span>]</span></a></sup></p>
<p>Metformin is not metabolized, rather it is primarily excreted in the urine with an elimination half-life of 6.2 hours.<sup id="cite_ref-Heller_45-0" class="reference"><a href="#cite_note-Heller-45" title=""><span>[</span>46<span>]</span></a></sup></p>
<p><a name="Interactions" id="Interactions"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=9" title="Edit section: Interactions">edit</a>]</span> <span class="mw-headline">Interactions</span></h2>
<p>The <a href="/wiki/H2_antagonist" title="H2 antagonist">H<sub>2</sub>-receptor antagonist</a> <a href="/wiki/Cimetidine" title="Cimetidine">cimetidine</a> causes an increase in the plasma concentration of metformin, by reducing <a href="/wiki/Clearance_(medicine)" title="Clearance (medicine)">clearance</a> of metformin by the kidneys;<sup id="cite_ref-46" class="reference"><a href="#cite_note-46" title=""><span>[</span>47<span>]</span></a></sup> both metformin and cimetidine are cleared from the body by <a href="/wiki/Renal_physiology#Secretion" title="Renal physiology">tubular secretion</a>, and both, particularly the <a href="/wiki/Cation" title="Cation" class="mw-redirect">cationic</a> (positively <a href="/wiki/Electric_charge" title="Electric charge">charged</a>) form of cimetidine, may compete for the same transport mechanism.<sup id="cite_ref-RxList_47-0" class="reference"><a href="#cite_note-RxList-47" title=""><span>[</span>48<span>]</span></a></sup> A small <a href="/wiki/Blind_experiment" title="Blind experiment">double-blind</a>, <a href="/wiki/Randomized_controlled_trial" title="Randomized controlled trial">randomized</a> study found the <a href="/wiki/Antibiotic" title="Antibiotic">antibiotic</a> <a href="/wiki/Cefalexin" title="Cefalexin">cefalexin</a> to also increase metformin concentrations by a similar mechanism;<sup id="cite_ref-48" class="reference"><a href="#cite_note-48" title=""><span>[</span>49<span>]</span></a></sup> theoretically, other cationic medications may produce the same effect.<sup id="cite_ref-RxList_47-1" class="reference"><a href="#cite_note-RxList-47" title=""><span>[</span>48<span>]</span></a></sup></p>
<p><a name="Formulations" id="Formulations"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=10" title="Edit section: Formulations">edit</a>]</span> <span class="mw-headline">Formulations</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:202px;"><a href="/wiki/File:Metformin_500mg_Tablets.jpg" class="image" title="Metformin 500&#160;mg tablets"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/d/db/Metformin_500mg_Tablets.jpg/200px-Metformin_500mg_Tablets.jpg" width="200" height="152" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Metformin_500mg_Tablets.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Metformin 500&#160;mg tablets</div>
</div>
</div>
<p>Metformin IR (immediate release) is available in 500 mg, 850 mg, and 1000 mg tablets, all now generic in the US.</p>
<p>Metformin SR (slow release) or XR (extended release) was introduced in 2004, in 500&#160;mg and 750&#160;mg strengths, mainly to counteract the most common gastrointestinal side effects, as well as to increase patient compliance by reducing <a href="/wiki/Pill_burden" title="Pill burden" class="mw-redirect">pill burden</a>. No difference in effectiveness exists between the two preparations.</p>
<p><a name="Combinations_with_other_drugs" id="Combinations_with_other_drugs"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=11" title="Edit section: Combinations with other drugs">edit</a>]</span> <span class="mw-headline">Combinations with other drugs</span></h3>
<p>Metformin is often prescribed to <a href="/wiki/Diabetes_mellitus_type_2" title="Diabetes mellitus type 2">type 2</a> diabetes patients in combination with <a href="/wiki/Rosiglitazone" title="Rosiglitazone">rosiglitazone</a>. This drug actively reduces insulin resistance, complementing the action of the metformin. In 2002, the two drugs were combined into a single product, <b>Avandamet</b>, marketed by <a href="/wiki/GlaxoSmithKline" title="GlaxoSmithKline">GlaxoSmithKline</a>.<sup id="cite_ref-49" class="reference"><a href="#cite_note-49" title=""><span>[</span>50<span>]</span></a></sup> In 2005, all current stock of Avandamet was seized by the FDA and removed from the market, after inspections showed the factory where it was produced was violating <a href="/wiki/Good_Manufacturing_Practice" title="Good Manufacturing Practice" class="mw-redirect">Good Manufacturing Practices</a>.<sup id="cite_ref-50" class="reference"><a href="#cite_note-50" title=""><span>[</span>51<span>]</span></a></sup> The drug pair continued to be prescribed separately in the absence of Avandamet, which was available again by the end of that year.</p>
<p>In the United States, metformin is also available in combination with <a href="/wiki/Pioglitazone" title="Pioglitazone">pioglitazone</a> (trade name <b>Actoplus Met</b>), the <a href="/wiki/Sulfonylurea" title="Sulfonylurea">sulfonylureas</a> <a href="/wiki/Glipizide" title="Glipizide">glipizide</a> (trade name <b>Metaglip</b>) and <a href="/wiki/Glibenclamide" title="Glibenclamide">glibenclamide</a> (known as <i>glyburide</i> in the United States, trade name <b>Glucovance</b>), the <a href="/wiki/Dipeptidyl_peptidase-4_inhibitors" title="Dipeptidyl peptidase-4 inhibitors" class="mw-redirect">dipeptidyl peptidase-4 inhibitor</a> <a href="/wiki/Sitagliptin" title="Sitagliptin">sitagliptin</a> (trade name <b>Janumet</b>), and the <a href="/wiki/Meglitinide" title="Meglitinide">meglitinide</a> <a href="/wiki/Repaglinide" title="Repaglinide">repaglinide</a> (<b>PrandiMet</b>). Generic formulations of metformin/glipizide and metformin/glibenclamide are available. A generic formulation of metformin/rosiglitazone from <a href="/wiki/Teva_Pharmaceutical_Industries" title="Teva Pharmaceutical Industries">Teva</a> has received tentative approval from the FDA, and is expected to reach the market in early 2012.<sup id="cite_ref-51" class="reference"><a href="#cite_note-51" title=""><span>[</span>52<span>]</span></a></sup></p>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=12" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small references-column-count references-column-count-2" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-0"><b><a href="#cite_ref-0" title="">^</a></b> Clinical Guidelines Task Force, <a href="/wiki/International_Diabetes_Federation" title="International Diabetes Federation">International Diabetes Federation</a> (2005). <span class="PDFlink"><a href="http://www.idf.org/webdata/docs/GGT2D%2009%20Oral%20therapy.pdf" class="external text" title="http://www.idf.org/webdata/docs/GGT2D%2009%20Oral%20therapy.pdf" rel="nofollow">"Glucose control: oral therapy"</a></span><span style="font-size:smaller;"><a href="/wiki/Portable_Document_Format" title="Portable Document Format">PDF</a>&#160;(100&#160;KB)</span>. In: <i>Global Guideline for Type 2 Diabetes</i>. <a href="/wiki/Brussels" title="Brussels">Brussels</a>: International Diabetes Federation, 35–8. Retrieved on November 6, 2007.</li>
<li id="cite_note-1"><b><a href="#cite_ref-1" title="">^</a></b> <a href="/wiki/National_Institute_for_Health_and_Clinical_Excellence" title="National Institute for Health and Clinical Excellence">National Institute for Health and Clinical Excellence</a>. <i><a href="http://guidance.nice.org.uk/CG66" class="external text" title="http://guidance.nice.org.uk/CG66" rel="nofollow">Clinical guideline 66: Diabetes - type 2 (update)</a></i>. London, 2008.</li>
<li id="cite_note-2"><b><a href="#cite_ref-2" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREF.5B.5BAmerican_Diabetes_Association.5D.5D2007"><a href="/wiki/American_Diabetes_Association" title="American Diabetes Association">American Diabetes Association</a> (2007). "<a href="http://care.diabetesjournals.org/cgi/content/full/30/suppl_1/S4" class="external text" title="http://care.diabetesjournals.org/cgi/content/full/30/suppl_1/S4" rel="nofollow">Standards of medical care in diabetes—2007</a>". <i>Diabetes Care</i> <b>30 Suppl 1</b>: S4–S41. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2337%2Fdc07-S004" class="external text" title="http://dx.doi.org/10.2337%2Fdc07-S004" rel="nofollow">10.2337/dc07-S004</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17192377" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17192377">PMID 17192377</a><span class="printonly">. <a href="http://care.diabetesjournals.org/cgi/content/full/30/suppl_1/S4" class="external free" title="http://care.diabetesjournals.org/cgi/content/full/30/suppl_1/S4" rel="nofollow">http://care.diabetesjournals.org/cgi/content/full/30/suppl_1/S4</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Standards+of+medical+care+in+diabetes%E2%80%942007&amp;rft.jtitle=Diabetes+Care&amp;rft.aulast=%5B%5BAmerican+Diabetes+Association%5D%5D&amp;rft.au=%5B%5BAmerican+Diabetes+Association%5D%5D&amp;rft.date=2007&amp;rft.volume=30+Suppl+1&amp;rft.pages=S4%E2%80%93S41&amp;rft_id=info:doi/10.2337%2Fdc07-S004&amp;rft_id=info:pmid/17192377&amp;rft_id=http%3A%2F%2Fcare.diabetesjournals.org%2Fcgi%2Fcontent%2Ffull%2F30%2Fsuppl_1%2FS4&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Eurich-3">^ <a href="#cite_ref-Eurich_3-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Eurich_3-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFEurich_DT.2C_McAlister_FA.2C_Blackburn_DF.2C_.27.27et_al..27.272007">Eurich DT, McAlister FA, Blackburn DF, <i>et al.</i> (2007). "<a href="http://www.bmj.com/cgi/content/full/335/7618/497" class="external text" title="http://www.bmj.com/cgi/content/full/335/7618/497" rel="nofollow">Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review</a>". <i>BMJ</i> <b>335</b> (7618): 497. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fbmj.39314.620174.80" class="external text" title="http://dx.doi.org/10.1136%2Fbmj.39314.620174.80" rel="nofollow">10.1136/bmj.39314.620174.80</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17761999" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17761999">PMID 17761999</a><span class="printonly">. <a href="http://www.bmj.com/cgi/content/full/335/7618/497" class="external free" title="http://www.bmj.com/cgi/content/full/335/7618/497" rel="nofollow">http://www.bmj.com/cgi/content/full/335/7618/497</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Benefits+and+harms+of+antidiabetic+agents+in+patients+with+diabetes+and+heart+failure%3A+systematic+review&amp;rft.jtitle=BMJ&amp;rft.aulast=Eurich+DT%2C+McAlister+FA%2C+Blackburn+DF%2C+%27%27et+al.%27%27&amp;rft.au=Eurich+DT%2C+McAlister+FA%2C+Blackburn+DF%2C+%27%27et+al.%27%27&amp;rft.date=2007&amp;rft.volume=335&amp;rft.issue=7618&amp;rft.pages=497&amp;rft_id=info:doi/10.1136%2Fbmj.39314.620174.80&amp;rft_id=info:pmid/17761999&amp;rft_id=http%3A%2F%2Fwww.bmj.com%2Fcgi%2Fcontent%2Ffull%2F335%2F7618%2F497&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-4"><b><a href="#cite_ref-4" title="">^</a></b> <span class="PDFlink"><a href="http://www.drugtopics.com/drugtopics/data/articlestandard/drugtopics/092007/407652/article.pdf" class="external text" title="http://www.drugtopics.com/drugtopics/data/articlestandard/drugtopics/092007/407652/article.pdf" rel="nofollow">Top 200 Generic Drugs by Units in 2006</a></span><span style="font-size:smaller;"><a href="/wiki/Portable_Document_Format" title="Portable Document Format">PDF</a>&#160;(19.4&#160;KB)</span>. <i>Drug Topics</i> (March 5, 2007). Retrieved on April 8, 2007.</li>
<li id="cite_note-5"><b><a href="#cite_ref-5" title="">^</a></b> (March 2007) <span class="PDFlink"><a href="http://www.who.int/medicines/publications/EML15.pdf" class="external text" title="http://www.who.int/medicines/publications/EML15.pdf" rel="nofollow"><i>WHO Model List of Essential Medicines</i></a></span><span style="font-size:smaller;"><a href="/wiki/Portable_Document_Format" title="Portable Document Format">PDF</a>&#160;(612&#160;KB)</span>, 15<sup>th</sup> edition, <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a>, p. 21. Retrieved on <span class="mw-formatted-date" title="2007-11-19"><a href="/wiki/2007" title="2007">2007</a>-<a href="/wiki/November_19" title="November 19">11-19</a></span>.</li>
<li id="cite_note-Witters-6"><b><a href="#cite_ref-Witters_6-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWitters_L2001">Witters L (2001). "The blooming of the French lilac". <i>J Clin Invest</i> <b>108</b> (8): 1105–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1172%2FJCI14178" class="external text" title="http://dx.doi.org/10.1172%2FJCI14178" rel="nofollow">10.1172/JCI14178</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11602616" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11602616">PMID 11602616</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+blooming+of+the+French+lilac&amp;rft.jtitle=J+Clin+Invest&amp;rft.aulast=Witters+L&amp;rft.au=Witters+L&amp;rft.date=2001&amp;rft.volume=108&amp;rft.issue=8&amp;rft.pages=1105%E2%80%937&amp;rft_id=info:doi/10.1172%2FJCI14178&amp;rft_id=info:pmid/11602616&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span> Full text at <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>: <a href="http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=209536" class="external text" title="http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=209536" rel="nofollow">209536</a></li>
<li id="cite_note-Ungar-7"><b><a href="#cite_ref-Ungar_7-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFUngar_G.2C_Freedman_L.2C_Shapiro_S1957">Ungar G, Freedman L, Shapiro S (1957). "Pharmacological studies of a new oral hypoglycemic drug". <i>Proc Soc Exp Biol Med</i> <b>95</b> (1): 190–2. <a href="http://www.ncbi.nlm.nih.gov/pubmed/13432032" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/13432032">PMID 13432032</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pharmacological+studies+of+a+new+oral+hypoglycemic+drug&amp;rft.jtitle=Proc+Soc+Exp+Biol+Med&amp;rft.aulast=Ungar+G%2C+Freedman+L%2C+Shapiro+S&amp;rft.au=Ungar+G%2C+Freedman+L%2C+Shapiro+S&amp;rft.date=1957&amp;rft.volume=95&amp;rft.issue=1&amp;rft.pages=190%E2%80%932&amp;rft_id=info:pmid/13432032&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-FDAapproval-8"><b><a href="#cite_ref-FDAapproval_8-0" title="">^</a></b> <cite style="font-style:normal" class="press release" id="CITEREFU.S._.5B.5BFood_and_Drug_Administration.5D.5D1994">U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration" class="mw-redirect">Food and Drug Administration</a> (December 30, 1994). <i><a href="http://www.fda.gov/bbs/topics/ANSWERS/ANS00627.html" class="external text" title="http://www.fda.gov/bbs/topics/ANSWERS/ANS00627.html" rel="nofollow">FDA Approves New Diabetes Drug</a></i>. <a href="/wiki/News_release" title="News release">Press release</a><span class="printonly">. <a href="http://www.fda.gov/bbs/topics/ANSWERS/ANS00627.html" class="external free" title="http://www.fda.gov/bbs/topics/ANSWERS/ANS00627.html" rel="nofollow">http://www.fda.gov/bbs/topics/ANSWERS/ANS00627.html</a></span><span class="reference-accessdate">. Retrieved on 2007-01-06</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=FDA+Approves+New+Diabetes+Drug&amp;rft.aulast=U.S.+%5B%5BFood+and+Drug+Administration%5D%5D&amp;rft.au=U.S.+%5B%5BFood+and+Drug+Administration%5D%5D&amp;rft.date=December+30%2C+1994&amp;rft.series=%5B%5BNews+release%7CPress+release%5D%5D&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fbbs%2Ftopics%2FANSWERS%2FANS00627.html&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-9"><b><a href="#cite_ref-9" title="">^</a></b> GLUCOPHAGE Label and Approval History. U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration" class="mw-redirect">Food and Drug Administration</a>. Retrieved on <span class="mw-formatted-date" title="2007-01-08"><a href="/wiki/2007" title="2007">2007</a>-<a href="/wiki/January_8" title="January 8">01-08</a></span>. Data available for download on <a href="http://www.fda.gov/cder/drugsatfda/datafiles/default.htm" class="external text" title="http://www.fda.gov/cder/drugsatfda/datafiles/default.htm" rel="nofollow">FDA website</a>.</li>
<li id="cite_note-10"><b><a href="#cite_ref-10" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSelvin_E.2C_Bolen_S.2C_Yeh_HC.2C_.27.27et_al.27.272008">Selvin E, Bolen S, Yeh HC, <i>et al</i> (October 2008). "Cardiovascular outcomes in trials of oral diabetes medications: a systematic review". <i>Arch Intern Med</i> <b>168</b> (19): 2070–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Farchinte.168.19.2070" class="external text" title="http://dx.doi.org/10.1001%2Farchinte.168.19.2070" rel="nofollow">10.1001/archinte.168.19.2070</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18955635" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18955635">PMID 18955635</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cardiovascular+outcomes+in+trials+of+oral+diabetes+medications%3A+a+systematic+review&amp;rft.jtitle=Arch+Intern+Med&amp;rft.aulast=Selvin+E%2C+Bolen+S%2C+Yeh+HC%2C+%27%27et+al%27%27&amp;rft.au=Selvin+E%2C+Bolen+S%2C+Yeh+HC%2C+%27%27et+al%27%27&amp;rft.date=October+2008&amp;rft.volume=168&amp;rft.issue=19&amp;rft.pages=2070%E2%80%9380&amp;rft_id=info:doi/10.1001%2Farchinte.168.19.2070&amp;rft_id=info:pmid/18955635&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-UKPDS-11"><b><a href="#cite_ref-UKPDS_11-0" title="">^</a></b> <cite style="font-style:normal" class="">"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group". <i>Lancet</i> <b>352</b> (9131): 854–65. 1998. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2898%2907037-8" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2898%2907037-8" rel="nofollow">10.1016/S0140-6736(98)07037-8</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9742977" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9742977">PMID 9742977</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effect+of+intensive+blood-glucose+control+with+metformin+on+complications+in+overweight+patients+with+type+2+diabetes+%28UKPDS+34%29.+UK+Prospective+Diabetes+Study+%28UKPDS%29+Group&amp;rft.jtitle=Lancet&amp;rft.date=1998&amp;rft.volume=352&amp;rft.issue=9131&amp;rft.pages=854%E2%80%9365&amp;rft_id=info:doi/10.1016%2FS0140-6736%2898%2907037-8&amp;rft_id=info:pmid/9742977&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-12"><b><a href="#cite_ref-12" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKilo_C.2C_Mezitis_N.2C_Jain_R.2C_Mersey_J.2C_McGill_J.2C_Raskin_P2003">Kilo C, Mezitis N, Jain R, Mersey J, McGill J, Raskin P (2003). "Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin". <i>J Diabetes Complications</i> <b>17</b> (6): 307–13. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS1056-8727%2803%2900076-X" class="external text" title="http://dx.doi.org/10.1016%2FS1056-8727%2803%2900076-X" rel="nofollow">10.1016/S1056-8727(03)00076-X</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14583174" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14583174">PMID 14583174</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Starting+patients+with+type+2+diabetes+on+insulin+therapy+using+once-daily+injections+of+biphasic+insulin+aspart+70%2F30%2C+biphasic+human+insulin+70%2F30%2C+or+NPH+insulin+in+combination+with+metformin&amp;rft.jtitle=J+Diabetes+Complications&amp;rft.aulast=Kilo+C%2C+Mezitis+N%2C+Jain+R%2C+Mersey+J%2C+McGill+J%2C+Raskin+P&amp;rft.au=Kilo+C%2C+Mezitis+N%2C+Jain+R%2C+Mersey+J%2C+McGill+J%2C+Raskin+P&amp;rft.date=2003&amp;rft.volume=17&amp;rft.issue=6&amp;rft.pages=307%E2%80%9313&amp;rft_id=info:doi/10.1016%2FS1056-8727%2803%2900076-X&amp;rft_id=info:pmid/14583174&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-isbn0071416137-13"><b><a href="#cite_ref-isbn0071416137_13-0" title="">^</a></b> <cite style="font-style:normal" class="book" id="CITEREFDiPiro.2C_Joseph_T..3B_Talbert.2C_Robert_L..3B_Yee.2C_Gary_C..3B_Matzke.2C_Gary_R..3B_Wells.2C_Barbara_G..3B_Posey.2C_L._Michael2005">DiPiro, Joseph T.; Talbert, Robert L.; Yee, Gary C.; Matzke, Gary R.; Wells, Barbara G.; Posey, L. Michael (2005). <i>Pharmacotherapy: a pathophysiologic approach</i>. New York: McGraw-Hill. <a href="/wiki/Special:BookSources/0071416137" class="internal">ISBN 0071416137</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Pharmacotherapy%3A+a+pathophysiologic+approach&amp;rft.aulast=DiPiro%2C+Joseph+T.%3B+Talbert%2C+Robert+L.%3B+Yee%2C+Gary+C.%3B+Matzke%2C+Gary+R.%3B+Wells%2C+Barbara+G.%3B+Posey%2C+L.+Michael&amp;rft.au=DiPiro%2C+Joseph+T.%3B+Talbert%2C+Robert+L.%3B+Yee%2C+Gary+C.%3B+Matzke%2C+Gary+R.%3B+Wells%2C+Barbara+G.%3B+Posey%2C+L.+Michael&amp;rft.date=2005&amp;rft.place=New+York&amp;rft.pub=McGraw-Hill&amp;rft.isbn=0071416137&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-14"><b><a href="#cite_ref-14" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFStumvoll_M.2C_Nurjhan_N.2C_Perriello_G.2C_Dailey_G.2C_Gerich_JE1995">Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE (1995). "<a href="http://content.nejm.org/cgi/content/abstract/333/9/550" class="external text" title="http://content.nejm.org/cgi/content/abstract/333/9/550" rel="nofollow">Metabolic effects of metformin in non-insulin-dependent diabetes mellitus</a>". <i>N Engl J Med</i> <b>333</b> (9): 550–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJM199508313330903" class="external text" title="http://dx.doi.org/10.1056%2FNEJM199508313330903" rel="nofollow">10.1056/NEJM199508313330903</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7623903" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/7623903">PMID 7623903</a><span class="printonly">. <a href="http://content.nejm.org/cgi/content/abstract/333/9/550" class="external free" title="http://content.nejm.org/cgi/content/abstract/333/9/550" rel="nofollow">http://content.nejm.org/cgi/content/abstract/333/9/550</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Metabolic+effects+of+metformin+in+non-insulin-dependent+diabetes+mellitus&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=Stumvoll+M%2C+Nurjhan+N%2C+Perriello+G%2C+Dailey+G%2C+Gerich+JE&amp;rft.au=Stumvoll+M%2C+Nurjhan+N%2C+Perriello+G%2C+Dailey+G%2C+Gerich+JE&amp;rft.date=1995&amp;rft.volume=333&amp;rft.issue=9&amp;rft.pages=550%E2%80%934&amp;rft_id=info:doi/10.1056%2FNEJM199508313330903&amp;rft_id=info:pmid/7623903&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Fabstract%2F333%2F9%2F550&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Bolen-15">^ <a href="#cite_ref-Bolen_15-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Bolen_15-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFBolen_S.2C_Feldman_L.2C_Vassy_J.2C_.27.27et_al.27.272007">Bolen S, Feldman L, Vassy J, <i>et al</i> (2007). "Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus". <i>Ann Intern Med</i> <b>147</b> (6): 386–99. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17638715" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17638715">PMID 17638715</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Systematic+review%3A+comparative+effectiveness+and+safety+of+oral+medications+for+type+2+diabetes+mellitus&amp;rft.jtitle=Ann+Intern+Med&amp;rft.aulast=Bolen+S%2C+Feldman+L%2C+Vassy+J%2C+%27%27et+al%27%27&amp;rft.au=Bolen+S%2C+Feldman+L%2C+Vassy+J%2C+%27%27et+al%27%27&amp;rft.date=2007&amp;rft.volume=147&amp;rft.issue=6&amp;rft.pages=386%E2%80%9399&amp;rft_id=info:pmid/17638715&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Lord-16"><b><a href="#cite_ref-Lord_16-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLord_JM.2C_Flight_IHK.2C_Norman_RJ2003">Lord JM, Flight IHK, Norman RJ (2003). "<a href="http://www.bmj.com/cgi/content/full/327/7421/951" class="external text" title="http://www.bmj.com/cgi/content/full/327/7421/951" rel="nofollow">Metformin in polycystic ovary syndrome: systematic review and meta-analysis</a>". <i>BMJ</i> <b>327</b> (7421): 951–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fbmj.327.7421.951" class="external text" title="http://dx.doi.org/10.1136%2Fbmj.327.7421.951" rel="nofollow">10.1136/bmj.327.7421.951</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14576245" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14576245">PMID 14576245</a><span class="printonly">. <a href="http://www.bmj.com/cgi/content/full/327/7421/951" class="external free" title="http://www.bmj.com/cgi/content/full/327/7421/951" rel="nofollow">http://www.bmj.com/cgi/content/full/327/7421/951</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Metformin+in+polycystic+ovary+syndrome%3A+systematic+review+and+meta-analysis&amp;rft.jtitle=BMJ&amp;rft.aulast=Lord+JM%2C+Flight+IHK%2C+Norman+RJ&amp;rft.au=Lord+JM%2C+Flight+IHK%2C+Norman+RJ&amp;rft.date=2003&amp;rft.volume=327&amp;rft.issue=7421&amp;rft.pages=951%E2%80%933&amp;rft_id=info:doi/10.1136%2Fbmj.327.7421.951&amp;rft_id=info:pmid/14576245&amp;rft_id=http%3A%2F%2Fwww.bmj.com%2Fcgi%2Fcontent%2Ffull%2F327%2F7421%2F951&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Marchesini-17"><b><a href="#cite_ref-Marchesini_17-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMarchesini_G.2C_Brizi_M.2C_Bianchi_G.2C_Tomassetti_S.2C_Zoli_M.2C_Melchionda_N2001">Marchesini G, Brizi M, Bianchi G, Tomassetti S, Zoli M, Melchionda N (2001). "Metformin in non-alcoholic steatohepatitis". <i><a href="/wiki/The_Lancet" title="The Lancet">Lancet</a></i> <b>358</b> (9285): 893–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2801%2906042-1" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2801%2906042-1" rel="nofollow">10.1016/S0140-6736(01)06042-1</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11567710" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11567710">PMID 11567710</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Metformin+in+non-alcoholic+steatohepatitis&amp;rft.jtitle=%5B%5BThe+Lancet%7CLancet%5D%5D&amp;rft.aulast=Marchesini+G%2C+Brizi+M%2C+Bianchi+G%2C+Tomassetti+S%2C+Zoli+M%2C+Melchionda+N&amp;rft.au=Marchesini+G%2C+Brizi+M%2C+Bianchi+G%2C+Tomassetti+S%2C+Zoli+M%2C+Melchionda+N&amp;rft.date=2001&amp;rft.volume=358&amp;rft.issue=9285&amp;rft.pages=893%E2%80%934&amp;rft_id=info:doi/10.1016%2FS0140-6736%2801%2906042-1&amp;rft_id=info:pmid/11567710&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-18"><b><a href="#cite_ref-18" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFIb.C3.A1.C3.B1ez_L.2C_Ong_K.2C_Valls_C.2C_Marcos_MV.2C_Dunger_DB.2C_de_Zegher_F2006">Ibáñez L, Ong K, Valls C, Marcos MV, Dunger DB, de Zegher F (2006). "Metformin treatment to prevent early puberty in girls with precocious pubarche". <i>J. Clin. Endocrinol. Metab.</i> <b>91</b> (8): 2888–91. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1210%2Fjc.2006-0336" class="external text" title="http://dx.doi.org/10.1210%2Fjc.2006-0336" rel="nofollow">10.1210/jc.2006-0336</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16684823" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16684823">PMID 16684823</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Metformin+treatment+to+prevent+early+puberty+in+girls+with+precocious+pubarche&amp;rft.jtitle=J.+Clin.+Endocrinol.+Metab.&amp;rft.aulast=Ib%C3%A1%C3%B1ez+L%2C+Ong+K%2C+Valls+C%2C+Marcos+MV%2C+Dunger+DB%2C+de+Zegher+F&amp;rft.au=Ib%C3%A1%C3%B1ez+L%2C+Ong+K%2C+Valls+C%2C+Marcos+MV%2C+Dunger+DB%2C+de+Zegher+F&amp;rft.date=2006&amp;rft.volume=91&amp;rft.issue=8&amp;rft.pages=2888%E2%80%9391&amp;rft_id=info:doi/10.1210%2Fjc.2006-0336&amp;rft_id=info:pmid/16684823&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-NICE2004-19"><b><a href="#cite_ref-NICE2004_19-0" title="">^</a></b> <a href="/wiki/National_Institute_for_Health_and_Clinical_Excellence" title="National Institute for Health and Clinical Excellence">National Institute for Health and Clinical Excellence</a>. <i><a href="http://guidance.nice.org.uk/CG" class="external text" title="http://guidance.nice.org.uk/CG" rel="nofollow">11 Clinical guideline 11&#160;: Fertility: assessment and treatment for people with fertility problems</a></i> . London, 2004.</li>
<li id="cite_note-Nair-20"><b><a href="#cite_ref-Nair_20-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFNair_S.2C_Diehl_AM.2C_Wiseman_M.2C_Farr_GH_Jr.2C_Perrillo_RP2004">Nair S, Diehl AM, Wiseman M, Farr GH Jr, Perrillo RP (2004). "Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial". <i>Aliment Pharmacol Ther</i> <b>20</b> (1): 23–28. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1365-2036.2004.02025.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1365-2036.2004.02025.x" rel="nofollow">10.1111/j.1365-2036.2004.02025.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15225167" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15225167">PMID 15225167</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Metformin+in+the+treatment+of+non-alcoholic+steatohepatitis%3A+a+pilot+open+label+trial&amp;rft.jtitle=Aliment+Pharmacol+Ther&amp;rft.aulast=Nair+S%2C+Diehl+AM%2C+Wiseman+M%2C+Farr+GH+Jr%2C+Perrillo+RP&amp;rft.au=Nair+S%2C+Diehl+AM%2C+Wiseman+M%2C+Farr+GH+Jr%2C+Perrillo+RP&amp;rft.date=2004&amp;rft.volume=20&amp;rft.issue=1&amp;rft.pages=23%E2%80%9328&amp;rft_id=info:doi/10.1111%2Fj.1365-2036.2004.02025.x&amp;rft_id=info:pmid/15225167&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18182600-21"><b><a href="#cite_ref-pmid18182600_21-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWu_RR.2C_Zhao_JP.2C_Jin_H.2C_.27.27et_al.27.272008">Wu RR, Zhao JP, Jin H, <i>et al</i> (2008). "Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial". <i>JAMA</i> <b>299</b> (2): 185–93. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.2007.56-b" class="external text" title="http://dx.doi.org/10.1001%2Fjama.2007.56-b" rel="nofollow">10.1001/jama.2007.56-b</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18182600" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18182600">PMID 18182600</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Lifestyle+intervention+and+metformin+for+treatment+of+antipsychotic-induced+weight+gain%3A+a+randomized+controlled+trial&amp;rft.jtitle=JAMA&amp;rft.aulast=Wu+RR%2C+Zhao+JP%2C+Jin+H%2C+%27%27et+al%27%27&amp;rft.au=Wu+RR%2C+Zhao+JP%2C+Jin+H%2C+%27%27et+al%27%27&amp;rft.date=2008&amp;rft.volume=299&amp;rft.issue=2&amp;rft.pages=185%E2%80%9393&amp;rft_id=info:doi/10.1001%2Fjama.2007.56-b&amp;rft_id=info:pmid/18182600&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Jones2003-22"><b><a href="#cite_ref-Jones2003_22-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJones_G.2C_Macklin_J.2C_Alexander_W2003">Jones G, Macklin J, Alexander W (2003). "<a href="http://www.bmj.com/cgi/content/full/326/7379/4" class="external text" title="http://www.bmj.com/cgi/content/full/326/7379/4" rel="nofollow">Contraindications to the use of metformin</a>". <i>BMJ</i> <b>326</b> (7379): 4–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fbmj.326.7379.4" class="external text" title="http://dx.doi.org/10.1136%2Fbmj.326.7379.4" rel="nofollow">10.1136/bmj.326.7379.4</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12511434" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12511434">PMID 12511434</a><span class="printonly">. <a href="http://www.bmj.com/cgi/content/full/326/7379/4" class="external free" title="http://www.bmj.com/cgi/content/full/326/7379/4" rel="nofollow">http://www.bmj.com/cgi/content/full/326/7379/4</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Contraindications+to+the+use+of+metformin&amp;rft.jtitle=BMJ&amp;rft.aulast=Jones+G%2C+Macklin+J%2C+Alexander+W&amp;rft.au=Jones+G%2C+Macklin+J%2C+Alexander+W&amp;rft.date=2003&amp;rft.volume=326&amp;rft.issue=7379&amp;rft.pages=4%E2%80%935&amp;rft_id=info:doi/10.1136%2Fbmj.326.7379.4&amp;rft_id=info:pmid/12511434&amp;rft_id=http%3A%2F%2Fwww.bmj.com%2Fcgi%2Fcontent%2Ffull%2F326%2F7379%2F4&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-RCR-23">^ <a href="#cite_ref-RCR_23-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-RCR_23-1" title=""><sup><i><b>b</b></i></sup></a> Weir J (March 19, 1999). <a href="http://web.archive.org/web/20040104141219/http://www.rcr.ac.uk/pubtop.asp?PublicationID=70" class="external text" title="http://web.archive.org/web/20040104141219/http://www.rcr.ac.uk/pubtop.asp?PublicationID=70" rel="nofollow">Guidelines with Regard to Metformin-Induced Lactic Acidosis and X-ray Contrast Medium Agents</a>. <a href="/wiki/Royal_College_of_Radiologists" title="Royal College of Radiologists">Royal College of Radiologists</a>. Retrieved on <span class="mw-formatted-date" title="2007-10-26"><a href="/wiki/2007" title="2007">2007</a>-<a href="/wiki/October_26" title="October 26">10-26</a></span> through the <a href="/wiki/Internet_Archive" title="Internet Archive">Internet Archive</a>.</li>
<li id="cite_note-ESUR-24">^ <a href="#cite_ref-ESUR_24-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ESUR_24-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFThomsen_HS.2C_Morcos_SK2003">Thomsen HS, Morcos SK (2003). "<a href="http://bjr.birjournals.org/cgi/content/full/76/908/513" class="external text" title="http://bjr.birjournals.org/cgi/content/full/76/908/513" rel="nofollow">Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines</a>". <i>Br J Radiol</i> <b>76</b> (908): 513–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1259%2Fbjr%2F26964464" class="external text" title="http://dx.doi.org/10.1259%2Fbjr%2F26964464" rel="nofollow">10.1259/bjr/26964464</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12893691" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12893691">PMID 12893691</a><span class="printonly">. <a href="http://bjr.birjournals.org/cgi/content/full/76/908/513" class="external free" title="http://bjr.birjournals.org/cgi/content/full/76/908/513" rel="nofollow">http://bjr.birjournals.org/cgi/content/full/76/908/513</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Contrast+media+and+the+kidney%3A+European+Society+of+Urogenital+Radiology+%28ESUR%29+guidelines&amp;rft.jtitle=Br+J+Radiol&amp;rft.aulast=Thomsen+HS%2C+Morcos+SK&amp;rft.au=Thomsen+HS%2C+Morcos+SK&amp;rft.date=2003&amp;rft.volume=76&amp;rft.issue=908&amp;rft.pages=513%E2%80%938&amp;rft_id=info:doi/10.1259%2Fbjr%2F26964464&amp;rft_id=info:pmid/12893691&amp;rft_id=http%3A%2F%2Fbjr.birjournals.org%2Fcgi%2Fcontent%2Ffull%2F76%2F908%2F513&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Salpeter-25"><b><a href="#cite_ref-Salpeter_25-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSalpeter_S.2C_Greyber_E.2C_Pasternak_G.2C_Salpeter_E2003">Salpeter S, Greyber E, Pasternak G, Salpeter E (2003). "Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis". <i><a href="/wiki/Archives_of_Internal_Medicine" title="Archives of Internal Medicine">Arch Intern Med</a></i> <b>163</b> (21): 2594–602. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Farchinte.163.21.2594" class="external text" title="http://dx.doi.org/10.1001%2Farchinte.163.21.2594" rel="nofollow">10.1001/archinte.163.21.2594</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14638559" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14638559">PMID 14638559</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Risk+of+fatal+and+nonfatal+lactic+acidosis+with+metformin+use+in+type+2+diabetes+mellitus%3A+systematic+review+and+meta-analysis&amp;rft.jtitle=%5B%5BArchives+of+Internal+Medicine%7CArch+Intern+Med%5D%5D&amp;rft.aulast=Salpeter+S%2C+Greyber+E%2C+Pasternak+G%2C+Salpeter+E&amp;rft.au=Salpeter+S%2C+Greyber+E%2C+Pasternak+G%2C+Salpeter+E&amp;rft.date=2003&amp;rft.volume=163&amp;rft.issue=21&amp;rft.pages=2594%E2%80%93602&amp;rft_id=info:doi/10.1001%2Farchinte.163.21.2594&amp;rft_id=info:pmid/14638559&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-DF.26C-26"><b><a href="#cite_ref-DF.26C_26-0" title="">^</a></b> <cite style="font-style:normal" class="book"><i>Drug Facts and Comparisons 2005</i> (59th edition ed.). <a href="/wiki/Lippincott_Williams_%26_Wilkins" title="Lippincott Williams &amp; Wilkins">Lippincott Williams &amp; Wilkins</a>. October 2004. <a href="/wiki/Special:BookSources/1574391933" class="internal">ISBN 1-57439-193-3</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Drug+Facts+and+Comparisons+2005&amp;rft.date=October+2004&amp;rft.edition=59th+edition&amp;rft.pub=%5B%5BLippincott+Williams+%26+Wilkins%5D%5D&amp;rft.isbn=1-57439-193-3&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Wulffele-27"><b><a href="#cite_ref-Wulffele_27-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWulffele_MG.2C_Kooy_A.2C_Lehert_P.2C_Bets_D.2C_Ogterop_JC.2C_Borger_van_der_Burg_B.2C_Donker_AJ.2C_Stehouwer_CD.2003">Wulffele MG, Kooy A, Lehert P, Bets D, Ogterop JC, Borger van der Burg B, Donker AJ, Stehouwer CD. (November 2003). "Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial". <i>J Intern Med</i> <b>254</b> (5): 455–63. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1046%2Fj.1365-2796.2003.01213.x" class="external text" title="http://dx.doi.org/10.1046%2Fj.1365-2796.2003.01213.x" rel="nofollow">10.1046/j.1365-2796.2003.01213.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14535967" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14535967">PMID 14535967</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effects+of+short-term+treatment+with+metformin+on+serum+concentrations+of+homocysteine%2C+folate+and+vitamin+B12+in+type+2+diabetes+mellitus%3A+a+randomized%2C+placebo-controlled+trial&amp;rft.jtitle=J+Intern+Med&amp;rft.aulast=Wulffele+MG%2C+Kooy+A%2C+Lehert+P%2C+Bets+D%2C+Ogterop+JC%2C+Borger+van+der+Burg+B%2C+Donker+AJ%2C+Stehouwer+CD.&amp;rft.au=Wulffele+MG%2C+Kooy+A%2C+Lehert+P%2C+Bets+D%2C+Ogterop+JC%2C+Borger+van+der+Burg+B%2C+Donker+AJ%2C+Stehouwer+CD.&amp;rft.date=November+2003&amp;rft.volume=254&amp;rft.issue=5&amp;rft.pages=455%E2%80%9363&amp;rft_id=info:doi/10.1046%2Fj.1365-2796.2003.01213.x&amp;rft_id=info:pmid/14535967&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Andres-28"><b><a href="#cite_ref-Andres_28-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAndr.C3.A8s_E.2C_Noel_E.2C_Goichot_B2002">Andrès E, Noel E, Goichot B (2002). "Metformin-associated vitamin B12 deficiency". <i>Arch Intern Med</i> <b>162</b> (19): 2251–2. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Farchinte.162.19.2251-a" class="external text" title="http://dx.doi.org/10.1001%2Farchinte.162.19.2251-a" rel="nofollow">10.1001/archinte.162.19.2251-a</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12390080" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12390080">PMID 12390080</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Metformin-associated+vitamin+B12+deficiency&amp;rft.jtitle=Arch+Intern+Med&amp;rft.aulast=Andr%C3%A8s+E%2C+Noel+E%2C+Goichot+B&amp;rft.au=Andr%C3%A8s+E%2C+Noel+E%2C+Goichot+B&amp;rft.date=2002&amp;rft.volume=162&amp;rft.issue=19&amp;rft.pages=2251%E2%80%932&amp;rft_id=info:doi/10.1001%2Farchinte.162.19.2251-a&amp;rft_id=info:pmid/12390080&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Gilligan-29"><b><a href="#cite_ref-Gilligan_29-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGilligan_M2002">Gilligan M (2002). "Metformin and vitamin B12 deficiency". <i>Arch Intern Med</i> <b>162</b> (4): 484–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Farchinte.162.4.484" class="external text" title="http://dx.doi.org/10.1001%2Farchinte.162.4.484" rel="nofollow">10.1001/archinte.162.4.484</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11863489" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11863489">PMID 11863489</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Metformin+and+vitamin+B12+deficiency&amp;rft.jtitle=Arch+Intern+Med&amp;rft.aulast=Gilligan+M&amp;rft.au=Gilligan+M&amp;rft.date=2002&amp;rft.volume=162&amp;rft.issue=4&amp;rft.pages=484%E2%80%935&amp;rft_id=info:doi/10.1001%2Farchinte.162.4.484&amp;rft_id=info:pmid/11863489&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-30"><b><a href="#cite_ref-30" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTing_R.2C_Szeto_C.2C_Chan_M.2C_Ma_K.2C_Chow_K2006">Ting R, Szeto C, Chan M, Ma K, Chow K (2006). "Risk factors of vitamin B(12) deficiency in patients receiving metformin". <i>Arch Intern Med</i> <b>166</b> (18): 1975–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Farchinte.166.18.1975" class="external text" title="http://dx.doi.org/10.1001%2Farchinte.166.18.1975" rel="nofollow">10.1001/archinte.166.18.1975</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17030830" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17030830">PMID 17030830</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Risk+factors+of+vitamin+B%2812%29+deficiency+in+patients+receiving+metformin&amp;rft.jtitle=Arch+Intern+Med&amp;rft.aulast=Ting+R%2C+Szeto+C%2C+Chan+M%2C+Ma+K%2C+Chow+K&amp;rft.au=Ting+R%2C+Szeto+C%2C+Chan+M%2C+Ma+K%2C+Chow+K&amp;rft.date=2006&amp;rft.volume=166&amp;rft.issue=18&amp;rft.pages=1975%E2%80%939&amp;rft_id=info:doi/10.1001%2Farchinte.166.18.1975&amp;rft_id=info:pmid/17030830&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-31"><b><a href="#cite_ref-31" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSpiller_HA.2C_Quadrani_DA2004">Spiller HA, Quadrani DA (2004). "Toxic effects from metformin exposure". <i>The Annals of pharmacotherapy</i> <b>38</b> (5): 776–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1345%2Faph.1D468" class="external text" title="http://dx.doi.org/10.1345%2Faph.1D468" rel="nofollow">10.1345/aph.1D468</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15031415" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15031415">PMID 15031415</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Toxic+effects+from+metformin+exposure&amp;rft.jtitle=The+Annals+of+pharmacotherapy&amp;rft.aulast=Spiller+HA%2C+Quadrani+DA&amp;rft.au=Spiller+HA%2C+Quadrani+DA&amp;rft.date=2004&amp;rft.volume=38&amp;rft.issue=5&amp;rft.pages=776%E2%80%9380&amp;rft_id=info:doi/10.1345%2Faph.1D468&amp;rft_id=info:pmid/15031415&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-63g-32"><b><a href="#cite_ref-63g_32-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGjedde_S.2C_Christiansen_A.2C_Pedersen_SB.2C_Rungby_J2003">Gjedde S, Christiansen A, Pedersen SB, Rungby J (2003). "Survival following a metformin overdose of 63 g: a case report". <i>Pharmacol. Toxicol.</i> <b>93</b> (2): 98–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1034%2Fj.1600-0773.2003.930207.x" class="external text" title="http://dx.doi.org/10.1034%2Fj.1600-0773.2003.930207.x" rel="nofollow">10.1034/j.1600-0773.2003.930207.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12899672" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12899672">PMID 12899672</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Survival+following+a+metformin+overdose+of+63+g%3A+a+case+report&amp;rft.jtitle=Pharmacol.+Toxicol.&amp;rft.aulast=Gjedde+S%2C+Christiansen+A%2C+Pedersen+SB%2C+Rungby+J&amp;rft.au=Gjedde+S%2C+Christiansen+A%2C+Pedersen+SB%2C+Rungby+J&amp;rft.date=2003&amp;rft.volume=93&amp;rft.issue=2&amp;rft.pages=98%E2%80%939&amp;rft_id=info:doi/10.1034%2Fj.1600-0773.2003.930207.x&amp;rft_id=info:pmid/12899672&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-cvvh-33"><b><a href="#cite_ref-cvvh_33-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHarvey_B.2C_Hickman_C.2C_Hinson_G.2C_Ralph_T.2C_Mayer_A2005">Harvey B, Hickman C, Hinson G, Ralph T, Mayer A (2005). "Severe lactic acidosis complicating metformin overdose successfully treated with high-volume venovenous hemofiltration and aggressive alkalinization". <i>Pediatr Crit Care Med</i> <b>6</b> (5): 598–601. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16148825" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16148825">PMID 16148825</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Severe+lactic+acidosis+complicating+metformin+overdose+successfully+treated+with+high-volume+venovenous+hemofiltration+and+aggressive+alkalinization&amp;rft.jtitle=Pediatr+Crit+Care+Med&amp;rft.aulast=Harvey+B%2C+Hickman+C%2C+Hinson+G%2C+Ralph+T%2C+Mayer+A&amp;rft.au=Harvey+B%2C+Hickman+C%2C+Hinson+G%2C+Ralph+T%2C+Mayer+A&amp;rft.date=2005&amp;rft.volume=6&amp;rft.issue=5&amp;rft.pages=598%E2%80%93601&amp;rft_id=info:pmid/16148825&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-hd-34"><b><a href="#cite_ref-hd_34-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGuo_PY.2C_Storsley_LJ.2C_Finkle_SN2006">Guo PY, Storsley LJ, Finkle SN (2006). "Severe lactic acidosis treated with prolonged hemodialysis: recovery after massive overdoses of metformin". <i>Semin Dial</i> <b>19</b> (1): 80–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1525-139X.2006.00123.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1525-139X.2006.00123.x" rel="nofollow">10.1111/j.1525-139X.2006.00123.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16423187" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16423187">PMID 16423187</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Severe+lactic+acidosis+treated+with+prolonged+hemodialysis%3A+recovery+after+massive+overdoses+of+metformin&amp;rft.jtitle=Semin+Dial&amp;rft.aulast=Guo+PY%2C+Storsley+LJ%2C+Finkle+SN&amp;rft.au=Guo+PY%2C+Storsley+LJ%2C+Finkle+SN&amp;rft.date=2006&amp;rft.volume=19&amp;rft.issue=1&amp;rft.pages=80%E2%80%933&amp;rft_id=info:doi/10.1111%2Fj.1525-139X.2006.00123.x&amp;rft_id=info:pmid/16423187&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Kirpichnikov-35"><b><a href="#cite_ref-Kirpichnikov_35-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKirpichnikov_D.2C_McFarlane_SI.2C_Sowers_JR2002">Kirpichnikov D, McFarlane SI, Sowers JR (2002). "<a href="http://www.annals.org/cgi/reprint/137/1/25.pdf" class="external text" title="http://www.annals.org/cgi/reprint/137/1/25.pdf" rel="nofollow">Metformin: an update</a>" (PDF). <i>Ann Intern Med</i> <b>137</b> (1): 25–33. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12093242" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12093242">PMID 12093242</a><span class="printonly">. <a href="http://www.annals.org/cgi/reprint/137/1/25.pdf" class="external free" title="http://www.annals.org/cgi/reprint/137/1/25.pdf" rel="nofollow">http://www.annals.org/cgi/reprint/137/1/25.pdf</a></span><span class="reference-accessdate">. Retrieved on 2008-12-30</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Metformin%3A+an+update&amp;rft.jtitle=Ann+Intern+Med&amp;rft.aulast=Kirpichnikov+D%2C+McFarlane+SI%2C+Sowers+JR&amp;rft.au=Kirpichnikov+D%2C+McFarlane+SI%2C+Sowers+JR&amp;rft.date=2002&amp;rft.volume=137&amp;rft.issue=1&amp;rft.pages=25%E2%80%9333&amp;rft_id=info:pmid/12093242&amp;rft_id=http%3A%2F%2Fwww.annals.org%2Fcgi%2Freprint%2F137%2F1%2F25.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Hundal-36"><b><a href="#cite_ref-Hundal_36-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHundal_R.2C_Krssak_M.2C_Dufour_S.2C_Laurent_D.2C_Lebon_V.2C_Chandramouli_V.2C_Inzucchi_S.2C_Schumann_W.2C_Petersen_K.2C_Landau_B.2C_Shulman_G2000">Hundal R, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, Inzucchi S, Schumann W, Petersen K, Landau B, Shulman G (2000). "<a href="http://diabetes.diabetesjournals.org/cgi/reprint/49/12/2063" class="external text" title="http://diabetes.diabetesjournals.org/cgi/reprint/49/12/2063" rel="nofollow">Mechanism by which metformin reduces glucose production in type 2 diabetes</a>" (PDF). <i>Diabetes</i> <b>49</b> (12): 2063–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2337%2Fdiabetes.49.12.2063" class="external text" title="http://dx.doi.org/10.2337%2Fdiabetes.49.12.2063" rel="nofollow">10.2337/diabetes.49.12.2063</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11118008" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11118008">PMID 11118008</a><span class="printonly">. <a href="http://diabetes.diabetesjournals.org/cgi/reprint/49/12/2063" class="external free" title="http://diabetes.diabetesjournals.org/cgi/reprint/49/12/2063" rel="nofollow">http://diabetes.diabetesjournals.org/cgi/reprint/49/12/2063</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Mechanism+by+which+metformin+reduces+glucose+production+in+type+2+diabetes&amp;rft.jtitle=Diabetes&amp;rft.aulast=Hundal+R%2C+Krssak+M%2C+Dufour+S%2C+Laurent+D%2C+Lebon+V%2C+Chandramouli+V%2C+Inzucchi+S%2C+Schumann+W%2C+Petersen+K%2C+Landau+B%2C+Shulman+G&amp;rft.au=Hundal+R%2C+Krssak+M%2C+Dufour+S%2C+Laurent+D%2C+Lebon+V%2C+Chandramouli+V%2C+Inzucchi+S%2C+Schumann+W%2C+Petersen+K%2C+Landau+B%2C+Shulman+G&amp;rft.date=2000&amp;rft.volume=49&amp;rft.issue=12&amp;rft.pages=2063%E2%80%939&amp;rft_id=info:doi/10.2337%2Fdiabetes.49.12.2063&amp;rft_id=info:pmid/11118008&amp;rft_id=http%3A%2F%2Fdiabetes.diabetesjournals.org%2Fcgi%2Freprint%2F49%2F12%2F2063&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-37"><b><a href="#cite_ref-37" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTowler_MC.2C_Hardie_DG2007">Towler MC, Hardie DG (2007). "<a href="http://circres.ahajournals.org/cgi/content/full/100/3/328" class="external text" title="http://circres.ahajournals.org/cgi/content/full/100/3/328" rel="nofollow">AMP-activated protein kinase in metabolic control and insulin signaling</a>". <i>Circ Res</i> <b>100</b> (3): 328–41. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1161%2F01.RES.0000256090.42690.05" class="external text" title="http://dx.doi.org/10.1161%2F01.RES.0000256090.42690.05" rel="nofollow">10.1161/01.RES.0000256090.42690.05</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17307971" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17307971">PMID 17307971</a><span class="printonly">. <a href="http://circres.ahajournals.org/cgi/content/full/100/3/328" class="external free" title="http://circres.ahajournals.org/cgi/content/full/100/3/328" rel="nofollow">http://circres.ahajournals.org/cgi/content/full/100/3/328</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=AMP-activated+protein+kinase+in+metabolic+control+and+insulin+signaling&amp;rft.jtitle=Circ+Res&amp;rft.aulast=Towler+MC%2C+Hardie+DG&amp;rft.au=Towler+MC%2C+Hardie+DG&amp;rft.date=2007&amp;rft.volume=100&amp;rft.issue=3&amp;rft.pages=328%E2%80%9341&amp;rft_id=info:doi/10.1161%2F01.RES.0000256090.42690.05&amp;rft_id=info:pmid/17307971&amp;rft_id=http%3A%2F%2Fcircres.ahajournals.org%2Fcgi%2Fcontent%2Ffull%2F100%2F3%2F328&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Zhou-38"><b><a href="#cite_ref-Zhou_38-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFZhou_G.2C_Myers_R.2C_Li_Y.2C_Chen_Y.2C_Shen_X.2C_Fenyk-Melody_J.2C_Wu_M.2C_Ventre_J.2C_Doebber_T.2C_Fujii_N.2C_Musi_N.2C_Hirshman_M.2C_Goodyear_L.2C_Moller_D2001">Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman M, Goodyear L, Moller D (2001). "<a href="http://www.jci.org/cgi/content/full/108/8/1167#SEC4" class="external text" title="http://www.jci.org/cgi/content/full/108/8/1167#SEC4" rel="nofollow">Role of AMP-activated protein kinase in mechanism of metformin action</a>". <i>J Clin Invest</i> <b>108</b> (8): 1167–74. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1172%2FJCI13505" class="external text" title="http://dx.doi.org/10.1172%2FJCI13505" rel="nofollow">10.1172/JCI13505</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11602624" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11602624">PMID 11602624</a><span class="printonly">. <a href="http://www.jci.org/cgi/content/full/108/8/1167#SEC4" class="external free" title="http://www.jci.org/cgi/content/full/108/8/1167#SEC4" rel="nofollow">http://www.jci.org/cgi/content/full/108/8/1167#SEC4</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Role+of+AMP-activated+protein+kinase+in+mechanism+of+metformin+action&amp;rft.jtitle=J+Clin+Invest&amp;rft.aulast=Zhou+G%2C+Myers+R%2C+Li+Y%2C+Chen+Y%2C+Shen+X%2C+Fenyk-Melody+J%2C+Wu+M%2C+Ventre+J%2C+Doebber+T%2C+Fujii+N%2C+Musi+N%2C+Hirshman+M%2C+Goodyear+L%2C+Moller+D&amp;rft.au=Zhou+G%2C+Myers+R%2C+Li+Y%2C+Chen+Y%2C+Shen+X%2C+Fenyk-Melody+J%2C+Wu+M%2C+Ventre+J%2C+Doebber+T%2C+Fujii+N%2C+Musi+N%2C+Hirshman+M%2C+Goodyear+L%2C+Moller+D&amp;rft.date=2001&amp;rft.volume=108&amp;rft.issue=8&amp;rft.pages=1167%E2%80%9374&amp;rft_id=info:doi/10.1172%2FJCI13505&amp;rft_id=info:pmid/11602624&amp;rft_id=http%3A%2F%2Fwww.jci.org%2Fcgi%2Fcontent%2Ffull%2F108%2F8%2F1167%23SEC4&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-39"><b><a href="#cite_ref-39" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKim_YD.2C_Park_KG.2C_Lee_YS.2C_.27.27et_al..27.272008">Kim YD, Park KG, Lee YS, <i>et al.</i> (2008). "<a href="http://diabetes.diabetesjournals.org/cgi/content/full/57/2/306" class="external text" title="http://diabetes.diabetesjournals.org/cgi/content/full/57/2/306" rel="nofollow">Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP</a>". <i>Diabetes</i> <b>57</b> (2): 306–14. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2337%2Fdb07-0381" class="external text" title="http://dx.doi.org/10.2337%2Fdb07-0381" rel="nofollow">10.2337/db07-0381</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17909097" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17909097">PMID 17909097</a><span class="printonly">. <a href="http://diabetes.diabetesjournals.org/cgi/content/full/57/2/306" class="external free" title="http://diabetes.diabetesjournals.org/cgi/content/full/57/2/306" rel="nofollow">http://diabetes.diabetesjournals.org/cgi/content/full/57/2/306</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Metformin+inhibits+hepatic+gluconeogenesis+through+AMP-activated+protein+kinase-dependent+regulation+of+the+orphan+nuclear+receptor+SHP&amp;rft.jtitle=Diabetes&amp;rft.aulast=Kim+YD%2C+Park+KG%2C+Lee+YS%2C+%27%27et+al.%27%27&amp;rft.au=Kim+YD%2C+Park+KG%2C+Lee+YS%2C+%27%27et+al.%27%27&amp;rft.date=2008&amp;rft.volume=57&amp;rft.issue=2&amp;rft.pages=306%E2%80%9314&amp;rft_id=info:doi/10.2337%2Fdb07-0381&amp;rft_id=info:pmid/17909097&amp;rft_id=http%3A%2F%2Fdiabetes.diabetesjournals.org%2Fcgi%2Fcontent%2Ffull%2F57%2F2%2F306&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-40"><b><a href="#cite_ref-40" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFZhang_L.2C_He_H.2C_Balschi_JA2007">Zhang L, He H, Balschi JA (2007). "<a href="http://ajpheart.physiology.org/cgi/content/full/293/1/H457" class="external text" title="http://ajpheart.physiology.org/cgi/content/full/293/1/H457" rel="nofollow">Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration</a>". <i>Am J Physiol Heart Circ Physiol</i> <b>293</b> (1): H457–66. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1152%2Fajpheart.00002.2007" class="external text" title="http://dx.doi.org/10.1152%2Fajpheart.00002.2007" rel="nofollow">10.1152/ajpheart.00002.2007</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17369473" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17369473">PMID 17369473</a><span class="printonly">. <a href="http://ajpheart.physiology.org/cgi/content/full/293/1/H457" class="external free" title="http://ajpheart.physiology.org/cgi/content/full/293/1/H457" rel="nofollow">http://ajpheart.physiology.org/cgi/content/full/293/1/H457</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Metformin+and+phenformin+activate+AMP-activated+protein+kinase+in+the+heart+by+increasing+cytosolic+AMP+concentration&amp;rft.jtitle=Am+J+Physiol+Heart+Circ+Physiol&amp;rft.aulast=Zhang+L%2C+He+H%2C+Balschi+JA&amp;rft.au=Zhang+L%2C+He+H%2C+Balschi+JA&amp;rft.date=2007&amp;rft.volume=293&amp;rft.issue=1&amp;rft.pages=H457%E2%80%9366&amp;rft_id=info:doi/10.1152%2Fajpheart.00002.2007&amp;rft_id=info:pmid/17369473&amp;rft_id=http%3A%2F%2Fajpheart.physiology.org%2Fcgi%2Fcontent%2Ffull%2F293%2F1%2FH457&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-41"><b><a href="#cite_ref-41" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCollier_CA.2C_Bruce_CR.2C_Smith_AC.2C_Lopaschuk_G.2C_Dyck_DJ2006">Collier CA, Bruce CR, Smith AC, Lopaschuk G, Dyck DJ (2006). "Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle". <i>Am J Physiol Endocrinol Metab</i> <b>291</b> (1): E182-E189. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1152%2Fajpendo.00272.2005" class="external text" title="http://dx.doi.org/10.1152%2Fajpendo.00272.2005" rel="nofollow">10.1152/ajpendo.00272.2005</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16478780" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16478780">PMID 16478780</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Metformin+counters+the+insulin-induced+suppression+of+fatty+acid+oxidation+and+stimulation+of+triacylglycerol+storage+in+rodent+skeletal+muscle&amp;rft.jtitle=Am+J+Physiol+Endocrinol+Metab&amp;rft.aulast=Collier+CA%2C+Bruce+CR%2C+Smith+AC%2C+Lopaschuk+G%2C+Dyck+DJ&amp;rft.au=Collier+CA%2C+Bruce+CR%2C+Smith+AC%2C+Lopaschuk+G%2C+Dyck+DJ&amp;rft.date=2006&amp;rft.volume=291&amp;rft.issue=1&amp;rft.pages=E182-E189&amp;rft_id=info:doi/10.1152%2Fajpendo.00272.2005&amp;rft_id=info:pmid/16478780&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-42"><b><a href="#cite_ref-42" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBailey_CJ.2C_Turner_RC1996">Bailey CJ, Turner RC (1996). "Metformin". <i>N Engl J Med</i> <b>334</b> (9): 574–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJM199602293340906" class="external text" title="http://dx.doi.org/10.1056%2FNEJM199602293340906" rel="nofollow">10.1056/NEJM199602293340906</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8569826" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8569826">PMID 8569826</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Metformin&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=Bailey+CJ%2C+Turner+RC&amp;rft.au=Bailey+CJ%2C+Turner+RC&amp;rft.date=1996&amp;rft.volume=334&amp;rft.issue=9&amp;rft.pages=574%E2%80%939&amp;rft_id=info:doi/10.1056%2FNEJM199602293340906&amp;rft_id=info:pmid/8569826&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-43"><b><a href="#cite_ref-43" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMusi_N.2C_Hirshman_MF.2C_Nygren_J.2C_.27.27et_al..27.272002">Musi N, Hirshman MF, Nygren J, <i>et al.</i> (2002). "<a href="http://diabetes.diabetesjournals.org/cgi/content/full/51/7/2074" class="external text" title="http://diabetes.diabetesjournals.org/cgi/content/full/51/7/2074" rel="nofollow">Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes</a>". <i>Diabetes</i> <b>51</b> (7): 2074–81. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2337%2Fdiabetes.51.7.2074" class="external text" title="http://dx.doi.org/10.2337%2Fdiabetes.51.7.2074" rel="nofollow">10.2337/diabetes.51.7.2074</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12086935" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12086935">PMID 12086935</a><span class="printonly">. <a href="http://diabetes.diabetesjournals.org/cgi/content/full/51/7/2074" class="external free" title="http://diabetes.diabetesjournals.org/cgi/content/full/51/7/2074" rel="nofollow">http://diabetes.diabetesjournals.org/cgi/content/full/51/7/2074</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Metformin+increases+AMP-activated+protein+kinase+activity+in+skeletal+muscle+of+subjects+with+type+2+diabetes&amp;rft.jtitle=Diabetes&amp;rft.aulast=Musi+N%2C+Hirshman+MF%2C+Nygren+J%2C+%27%27et+al.%27%27&amp;rft.au=Musi+N%2C+Hirshman+MF%2C+Nygren+J%2C+%27%27et+al.%27%27&amp;rft.date=2002&amp;rft.volume=51&amp;rft.issue=7&amp;rft.pages=2074%E2%80%9381&amp;rft_id=info:doi/10.2337%2Fdiabetes.51.7.2074&amp;rft_id=info:pmid/12086935&amp;rft_id=http%3A%2F%2Fdiabetes.diabetesjournals.org%2Fcgi%2Fcontent%2Ffull%2F51%2F7%2F2074&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-44"><b><a href="#cite_ref-44" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSaeedi_R.2C_Parsons_HL.2C_Wambolt_RB.2C_.27.27et_al..27.272008">Saeedi R, Parsons HL, Wambolt RB, <i>et al.</i> (2008). "Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms". <i>Am J Physiol Heart Circ Physiol</i> <b>294</b> (6): H2497–506. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1152%2Fajpheart.00873.2007" class="external text" title="http://dx.doi.org/10.1152%2Fajpheart.00873.2007" rel="nofollow">10.1152/ajpheart.00873.2007</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18375721" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18375721">PMID 18375721</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Metabolic+actions+of+metformin+in+the+heart+can+occur+by+AMPK-independent+mechanisms&amp;rft.jtitle=Am+J+Physiol+Heart+Circ+Physiol&amp;rft.aulast=Saeedi+R%2C+Parsons+HL%2C+Wambolt+RB%2C+%27%27et+al.%27%27&amp;rft.au=Saeedi+R%2C+Parsons+HL%2C+Wambolt+RB%2C+%27%27et+al.%27%27&amp;rft.date=2008&amp;rft.volume=294&amp;rft.issue=6&amp;rft.pages=H2497%E2%80%93506&amp;rft_id=info:doi/10.1152%2Fajpheart.00873.2007&amp;rft_id=info:pmid/18375721&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Heller-45"><b><a href="#cite_ref-Heller_45-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHeller.2C_Jacqueline_B.2007">Heller, Jacqueline B. (2007). "<a href="http://www.aspca.org/site/DocServer/vetm0407_231-234.pdf?docID=11061" class="external text" title="http://www.aspca.org/site/DocServer/vetm0407_231-234.pdf?docID=11061" rel="nofollow">Metformin overdose in dogs and cats</a>". <i>Veterinary Medicine</i> (April): 231–233<span class="printonly">. <a href="http://www.aspca.org/site/DocServer/vetm0407_231-234.pdf?docID=11061" class="external free" title="http://www.aspca.org/site/DocServer/vetm0407_231-234.pdf?docID=11061" rel="nofollow">http://www.aspca.org/site/DocServer/vetm0407_231-234.pdf?docID=11061</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Metformin+overdose+in+dogs+and+cats&amp;rft.jtitle=Veterinary+Medicine&amp;rft.aulast=Heller%2C+Jacqueline+B.&amp;rft.au=Heller%2C+Jacqueline+B.&amp;rft.date=2007&amp;rft.issue=April&amp;rft.pages=231%E2%80%93233&amp;rft_id=http%3A%2F%2Fwww.aspca.org%2Fsite%2FDocServer%2Fvetm0407_231-234.pdf%3FdocID%3D11061&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-46"><b><a href="#cite_ref-46" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSomogyi_A.2C_Stockley_C.2C_Keal_J.2C_Rolan_P.2C_Bochner_F1987">Somogyi A, Stockley C, Keal J, Rolan P, Bochner F (1987). "Reduction of metformin renal tubular secretion by cimetidine in man". <i>Br J Clin Pharmacol</i> <b>23</b> (5): 545–51. <a href="http://www.ncbi.nlm.nih.gov/pubmed/3593625" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/3593625">PMID 3593625</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Reduction+of+metformin+renal+tubular+secretion+by+cimetidine+in+man&amp;rft.jtitle=Br+J+Clin+Pharmacol&amp;rft.aulast=Somogyi+A%2C+Stockley+C%2C+Keal+J%2C+Rolan+P%2C+Bochner+F&amp;rft.au=Somogyi+A%2C+Stockley+C%2C+Keal+J%2C+Rolan+P%2C+Bochner+F&amp;rft.date=1987&amp;rft.volume=23&amp;rft.issue=5&amp;rft.pages=545%E2%80%9351&amp;rft_id=info:pmid/3593625&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-RxList-47">^ <a href="#cite_ref-RxList_47-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-RxList_47-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="web"><a href="http://www.rxlist.com/cgi/generic/metformi_ad.htm" class="external text" title="http://www.rxlist.com/cgi/generic/metformi_ad.htm" rel="nofollow">"Glucophage Side Effects &amp; Drug Interactions"</a>. RxList.com. 2007<span class="printonly">. <a href="http://www.rxlist.com/cgi/generic/metformi_ad.htm" class="external free" title="http://www.rxlist.com/cgi/generic/metformi_ad.htm" rel="nofollow">http://www.rxlist.com/cgi/generic/metformi_ad.htm</a></span><span class="reference-accessdate">. Retrieved on 2007-11-19</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Glucophage+Side+Effects+%26+Drug+Interactions&amp;rft.atitle=&amp;rft.date=2007&amp;rft.pub=RxList.com&amp;rft_id=http%3A%2F%2Fwww.rxlist.com%2Fcgi%2Fgeneric%2Fmetformi_ad.htm&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-48"><b><a href="#cite_ref-48" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJayasagar_G.2C_Krishna_Kumar_M.2C_Chandrasekhar_K.2C_Madhusudan_Rao_C.2C_Madhusudan_Rao_Y2002">Jayasagar G, Krishna Kumar M, Chandrasekhar K, Madhusudan Rao C, Madhusudan Rao Y (2002). "Effect of cephalexin on the pharmacokinetics of metformin in healthy human volunteers". <i>Drug Metabol Drug Interact</i> <b>19</b> (1): 41–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12222753" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12222753">PMID 12222753</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effect+of+cephalexin+on+the+pharmacokinetics+of+metformin+in+healthy+human+volunteers&amp;rft.jtitle=Drug+Metabol+Drug+Interact&amp;rft.aulast=Jayasagar+G%2C+Krishna+Kumar+M%2C+Chandrasekhar+K%2C+Madhusudan+Rao+C%2C+Madhusudan+Rao+Y&amp;rft.au=Jayasagar+G%2C+Krishna+Kumar+M%2C+Chandrasekhar+K%2C+Madhusudan+Rao+C%2C+Madhusudan+Rao+Y&amp;rft.date=2002&amp;rft.volume=19&amp;rft.issue=1&amp;rft.pages=41%E2%80%938&amp;rft_id=info:pmid/12222753&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-49"><b><a href="#cite_ref-49" title="">^</a></b> <cite style="font-style:normal" class="press release" id="CITEREF.5B.5BGlaxoSmithKline.5D.5D2002"><a href="/wiki/GlaxoSmithKline" title="GlaxoSmithKline">GlaxoSmithKline</a> (October 12, 2002). <i><a href="http://www.docguide.com/news/content.nsf/news/8525697700573E1885256C4F0075B2B3" class="external text" title="http://www.docguide.com/news/content.nsf/news/8525697700573E1885256C4F0075B2B3" rel="nofollow">FDA Approves GlaxoSmithKline's Avandamet (rosiglitazone maleate and metformin HCl), The Latest Advancement in the Treatment of Type 2 Diabetes</a></i>. <a href="/wiki/News_release" title="News release">Press release</a><span class="printonly">. <a href="http://www.docguide.com/news/content.nsf/news/8525697700573E1885256C4F0075B2B3" class="external free" title="http://www.docguide.com/news/content.nsf/news/8525697700573E1885256C4F0075B2B3" rel="nofollow">http://www.docguide.com/news/content.nsf/news/8525697700573E1885256C4F0075B2B3</a></span><span class="reference-accessdate">. Retrieved on 2006-12-27</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=FDA+Approves+GlaxoSmithKline%27s+Avandamet+%28rosiglitazone+maleate+and+metformin+HCl%29%2C+The+Latest+Advancement+in+the+Treatment+of+Type+2+Diabetes&amp;rft.aulast=%5B%5BGlaxoSmithKline%5D%5D&amp;rft.au=%5B%5BGlaxoSmithKline%5D%5D&amp;rft.date=October+12%2C+2002&amp;rft.series=%5B%5BNews+release%7CPress+release%5D%5D&amp;rft_id=http%3A%2F%2Fwww.docguide.com%2Fnews%2Fcontent.nsf%2Fnews%2F8525697700573E1885256C4F0075B2B3&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-50"><b><a href="#cite_ref-50" title="">^</a></b> <cite style="font-style:normal" class="press release" id="CITEREFU.S._.5B.5BFood_and_Drug_Administration.5D.5D2005">U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration" class="mw-redirect">Food and Drug Administration</a> (March 4, 2005). <i><a href="http://www.fda.gov/oc/qanda/PaxilandAvandamet.html" class="external text" title="http://www.fda.gov/oc/qanda/PaxilandAvandamet.html" rel="nofollow">Questions and Answers about the Seizure of Paxil CR and Avandamet</a></i>. <a href="/wiki/News_release" title="News release">Press release</a><span class="printonly">. <a href="http://www.fda.gov/oc/qanda/PaxilandAvandamet.html" class="external free" title="http://www.fda.gov/oc/qanda/PaxilandAvandamet.html" rel="nofollow">http://www.fda.gov/oc/qanda/PaxilandAvandamet.html</a></span><span class="reference-accessdate">. Retrieved on 2006-12-27</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Questions+and+Answers+about+the+Seizure+of+Paxil+CR+and+Avandamet&amp;rft.aulast=U.S.+%5B%5BFood+and+Drug+Administration%5D%5D&amp;rft.au=U.S.+%5B%5BFood+and+Drug+Administration%5D%5D&amp;rft.date=March+4%2C+2005&amp;rft.series=%5B%5BNews+release%7CPress+release%5D%5D&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Foc%2Fqanda%2FPaxilandAvandamet.html&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-51"><b><a href="#cite_ref-51" title="">^</a></b> <cite style="font-style:normal" class="press release" id="CITEREF.5B.5BReuters.5D.5D2007"><a href="/wiki/Reuters" title="Reuters">Reuters</a> (September 27, 2007). <i><a href="http://www.reuters.com/article/inPlayBriefing/idUSIN20070927170530TEVA20070927" class="external text" title="http://www.reuters.com/article/inPlayBriefing/idUSIN20070927170530TEVA20070927" rel="nofollow">Teva Pharm announces settlement of generic Avandia, Avandamet, and Avandaryl litigation with GlaxoSmithKline</a></i>. <a href="/wiki/News_release" title="News release">Press release</a><span class="printonly">. <a href="http://www.reuters.com/article/inPlayBriefing/idUSIN20070927170530TEVA20070927" class="external free" title="http://www.reuters.com/article/inPlayBriefing/idUSIN20070927170530TEVA20070927" rel="nofollow">http://www.reuters.com/article/inPlayBriefing/idUSIN20070927170530TEVA20070927</a></span><span class="reference-accessdate">. Retrieved on 2009-02-17</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Teva+Pharm+announces+settlement+of+generic+Avandia%2C+Avandamet%2C+and+Avandaryl+litigation+with+GlaxoSmithKline&amp;rft.aulast=%5B%5BReuters%5D%5D&amp;rft.au=%5B%5BReuters%5D%5D&amp;rft.date=September+27%2C+2007&amp;rft.series=%5B%5BNews+release%7CPress+release%5D%5D&amp;rft_id=http%3A%2F%2Fwww.reuters.com%2Farticle%2FinPlayBriefing%2FidUSIN20070927170530TEVA20070927&amp;rfr_id=info:sid/en.wikipedia.org:Metformin"><span style="display: none;">&#160;</span></span></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=13" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<div class="noprint tright portal" style="border:solid #aaa 1px;margin:0.5em 0 0.5em 0.5em;">
<table style="background:#f9f9f9; font-size:85%; line-height:110%;">
<tr>
<td><a href="/wiki/File:Tabletten.JPG" class="image" title="Tabletten.JPG"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/5/5f/Tabletten.JPG/32px-Tabletten.JPG" width="32" height="26" border="0" /></a></td>
<td style="padding:0 0.2em;"><i><b><a href="/wiki/Portal:Pharmacy_and_Pharmacology" title="Portal:Pharmacy and Pharmacology">Pharmacy and Pharmacology portal</a></b></i></td>
</tr>
</table>
</div>
<ul>
<li><a href="http://www.dmoz.org/Health/Pharmacy/Drugs_and_Medications/M/Metformin/" class="external text" title="http://www.dmoz.org/Health/Pharmacy/Drugs_and_Medications/M/Metformin/" rel="nofollow">Metformin</a> at the <a href="/wiki/Open_Directory_Project" title="Open Directory Project">Open Directory Project</a></li>
<li><a href="http://www.merck.com/mmpe/lexicomp/metformin.html" class="external text" title="http://www.merck.com/mmpe/lexicomp/metformin.html" rel="nofollow">Metformin drug information</a> from Lexi-Comp. Includes dosage information and a comprehensive list of international brand names</li>
</ul>
<p><br clear="all" /></p>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;;border:none;; font-size:xx-small;"><a href="/wiki/Template:Oral_hypoglycemics_and_insulin_analogs" title="Template:Oral hypoglycemics and insulin analogs"><span title="View this template" style=";;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Oral_hypoglycemics_and_insulin_analogs" title="Template talk:Oral hypoglycemics and insulin analogs"><span title="Discussion about this template" style=";;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Oral_hypoglycemics_and_insulin_analogs&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Oral_hypoglycemics_and_insulin_analogs&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;">Oral <a href="/wiki/Anti-diabetic_drug" title="Anti-diabetic drug">anti-diabetic drugs</a> and <a href="/wiki/Insulin_analog" title="Insulin analog">Insulin analogs</a> (<a href="/wiki/ATC_code_A10" title="ATC code A10">A10</a>)</span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:#fd6;;"><a href="/wiki/Insulin" title="Insulin">Insulin</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Anti-diabetic_drug#Sensitizers" title="Anti-diabetic drug">Sensitizers</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Biguanide" title="Biguanide">Biguanides</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><strong class="selflink">Metformin</strong><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Buformin" title="Buformin">Buformin</a><sup>‡</sup><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Phenformin" title="Phenformin">Phenformin</a><sup>‡</sup></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Thiazolidinedione" title="Thiazolidinedione">TZDs</a> (<a href="/wiki/PPAR_modulator" title="PPAR modulator">PPAR</a>)</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Pioglitazone" title="Pioglitazone">Pioglitazone</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Rivoglitazone" title="Rivoglitazone">Rivoglitazone</a><sup>†</sup><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Rosiglitazone" title="Rosiglitazone">Rosiglitazone</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Troglitazone" title="Troglitazone">Troglitazone</a><sup>‡</sup></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/PPAR_modulator#Dual-PPAR_modulators" title="PPAR modulator">Dual PPAR agonists</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Aleglitazar" title="Aleglitazar">Aleglitazar</a><sup>†</sup><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Muraglitazar" title="Muraglitazar">Muraglitazar</a><sup>§</sup><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Tesaglitazar" title="Tesaglitazar">Tesaglitazar</a><sup>§</sup></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Anti-diabetic_drug#Secretagogues" title="Anti-diabetic drug">Secretagogues</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Sulfonylurea" title="Sulfonylurea">Sulfonylureas</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Sulfonylurea#First_generation" title="Sulfonylurea">1st generation</a>:</i> <a href="/wiki/Carbutamide" title="Carbutamide">Carbutamide</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Chlorpropamide" title="Chlorpropamide">Chlorpropamide</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Gliclazide" title="Gliclazide">Gliclazide</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Tolbutamide" title="Tolbutamide">Tolbutamide</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Tolazamide" title="Tolazamide">Tolazamide</a>
<p><i><a href="/wiki/Sulfonylurea#Second_generation" title="Sulfonylurea">2nd generation</a>:</i> <a href="/wiki/Glipizide" title="Glipizide">Glipizide</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Glibenclamide" title="Glibenclamide">Glibenclamide (Glyburide)</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Gliquidone" title="Gliquidone">Gliquidone</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Glyclopyramide" title="Glyclopyramide">Glyclopyramide</a></p>
<i><a href="/wiki/Sulfonylurea#Third_generation" title="Sulfonylurea">3rd generation</a>:</i> <a href="/wiki/Glimepiride" title="Glimepiride">Glimepiride</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Meglitinide" title="Meglitinide">Meglitinides</a>/"glinides" (<a href="/wiki/ATP-sensitive_potassium_channel" title="ATP-sensitive potassium channel">K+</a>)</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Nateglinide" title="Nateglinide">Nateglinide</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Repaglinide" title="Repaglinide">Repaglinide</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Mitiglinide" title="Mitiglinide">Mitiglinide</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Glucagon-like_peptide-1" title="Glucagon-like peptide-1">GLP-1</a> analog</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Exenatide" title="Exenatide">Exenatide</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Liraglutide" title="Liraglutide">Liraglutide</a><sup>†</sup><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Albiglutide" title="Albiglutide">Albiglutide</a><sup>†</sup></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dipeptidyl_peptidase-4_inhibitor" title="Dipeptidyl peptidase-4 inhibitor">DPP-4 inhibitors</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Alogliptin" title="Alogliptin">Alogliptin</a><sup>†</sup><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Linagliptin" title="Linagliptin">Linagliptin</a><sup>†</sup><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Saxagliptin" title="Saxagliptin">Saxagliptin</a><sup>†</sup><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Sitagliptin" title="Sitagliptin">Sitagliptin</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Vildagliptin" title="Vildagliptin">Vildagliptin</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Insulin_analog" title="Insulin analog">Analogs</a>/other insulins</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i>fast acting</i> (<a href="/wiki/Insulin_lispro" title="Insulin lispro">Insulin lispro</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Insulin_aspart" title="Insulin aspart">Insulin aspart</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Insulin_glulisine" title="Insulin glulisine">Insulin glulisine</a>)<span style="font-weight:bold;">&#160;·</span> <i>long acting</i> (<a href="/wiki/Insulin_glargine" title="Insulin glargine">Insulin glargine</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Insulin_detemir" title="Insulin detemir">Insulin detemir</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Inhalable_insulin" title="Inhalable insulin">Inhalable insulin (Exubera)</a><sup>‡</sup><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/NPH_insulin" title="NPH insulin">NPH insulin</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:#fd6;;">Other</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Alpha-glucosidase_inhibitor" title="Alpha-glucosidase inhibitor">Alpha-glucosidase inhibitors</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Acarbose" title="Acarbose">Acarbose</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Miglitol" title="Miglitol">Miglitol</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Voglibose" title="Voglibose">Voglibose</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Amylin" title="Amylin">Amylin</a> analog</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Pramlintide" title="Pramlintide">Pramlintide</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Sodium-glucose_transport_proteins" title="Sodium-glucose transport proteins">SGLT2</a> inhibitor</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Dapagliflozin" title="Dapagliflozin">Dapagliflozin</a><sup>†</sup><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Remogliflozin_etabonate" title="Remogliflozin etabonate">Remogliflozin</a><sup>†</sup><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Sergliflozin_etabonate" title="Sergliflozin etabonate">Sergliflozin</a><sup>†</sup></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;">Other</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Benfluorex" title="Benfluorex">Benfluorex</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Tolrestat" title="Tolrestat">Tolrestat</a><sup>‡</sup></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td colspan="2" style="width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><sup>†</sup>Undergoing <a href="/wiki/Clinical_trial" title="Clinical trial">clinical trials</a>. <sup>‡</sup> <a href="/wiki/List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market. <sup>§</sup><a href="/wiki/Drug_development" title="Drug development">Development</a> halted.</div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Preprocessor node count: 25350/1000000
Post-expand include size: 296562/2048000 bytes
Template argument size: 128530/2048000 bytes
Expensive parser function count: 0/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:253720-0!1!0!default!!en!2 and timestamp 20090403211637 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Metformin">http://en.wikipedia.org/wiki/Metformin</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Anti-diabetic_drugs" title="Category:Anti-diabetic drugs">Anti-diabetic drugs</a></span> | <span dir='ltr'><a href="/wiki/Category:Guanidines" title="Category:Guanidines">Guanidines</a></span> | <span dir='ltr'><a href="/wiki/Category:World_Health_Organization_essential_medicines" title="Category:World Health Organization essential medicines">World Health Organization essential medicines</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_2008" title="Category:Articles containing potentially dated statements from 2008">Articles containing potentially dated statements from 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:All_articles_containing_potentially_dated_statements" title="Category:All articles containing potentially dated statements">All articles containing potentially dated statements</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_2007" title="Category:Articles containing potentially dated statements from 2007">Articles containing potentially dated statements from 2007</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Metformin" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Metformin" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Metformin&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Metformin&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Metformin" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Metformin" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Metformin" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Metformin&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Metformin&amp;oldid=276830151" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Metformin&amp;id=276830151">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Metformin">Deutsch</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/Metformina">Español</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/Metformine">Français</a></li>
				<li class="interwiki-it"><a href="http://it.wikipedia.org/wiki/Metformina">Italiano</a></li>
				<li class="interwiki-hu"><a href="http://hu.wikipedia.org/wiki/Metformin">Magyar</a></li>
				<li class="interwiki-nl"><a href="http://nl.wikipedia.org/wiki/Metformine">Nederlands</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Metformina">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Metformina">Português</a></li>
				<li class="interwiki-ru"><a href="http://ru.wikipedia.org/wiki/%D0%9C%D0%B5%D1%82%D1%84%D0%BE%D1%80%D0%BC%D0%B8%D0%BD">Русский</a></li>
				<li class="interwiki-sq"><a href="http://sq.wikipedia.org/wiki/Metformin">Shqip</a></li>
				<li class="interwiki-fi"><a href="http://fi.wikipedia.org/wiki/Metformiini">Suomi</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 12 March 2009, at 21:11 (UTC).</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv196 in 0.048 secs. --></body></html>
